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ABSTRACT
The partial deficiency of ^'-nucleotidase activity found on 
the circulating mononuclear cells of many patients with 'common variable’ 
or 'X-linked' hypogammaglobulinaeraia was not due to abnormal compart- 
mentalisation of the enzyme, altered enzyme kinetics, or the presence of 
a regulatory factor. Isolation of subpopulations o*f mononuclear cells 
from normal adult blood showed that B-lymphocytes^ have about four times " 
more 5'-nucleotidase activity per cell than T-lymphocytes, and that 
monocytes have very little activity. Thus the absence of circulating B- 
lymphocytes in patients with X-linked hypogammaglo'bulinaemia contributed 
to the low activity in these patients, but some patients also had a low 
level of T-cell ^'-nucleotidase activity* The low enzyme level in 'common 
variable' hypogammaglobulinaemia,was due to one or more of three factors: 
a low T-cell activity, a reduced percentage of B-cells, and a low activity 
on the B-cells.
The ability of circulating mononuclear cells to migrate out of 
capillary tube cultures in vitro was unimpaired, and inhibition of the 
5’-nucleotidase activity of normal cells did not affect their migration. 
Inhibition of the 5'-nucleotidase activity also had no effect on the trans­
formation or immunoglobulin production of tonsil lymphocytes in vitro.
However, changes in the enzyme activity on tonsil lymphocytes were observed 
during cell transformation. Comparison of the ^'-nucleotidase activities 
of the circulating mononuclear cells from normal adults, cord blood, patients 
with chronic lymphatic leukemia, and from patients with hypogammaglobulinaeraia 
has led to the hypothesis that the low level of the enzyme on the lympho­
cytes of patients with 'common variable' and 'X-lirlcad' hypogammaglobulinaeraia 
is not the cause of the disease but reflects a stage of maturation arrest 
in these cells.
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INTRODUCTION
5'-Nucleotidase is widely employed as a marker enzjme for the plasma 
membrane, and little is known of its function in vivo. Clinical 
investigations with the mononuclear cells (lymphocytes and monocytes) of 
the peripheral blood from certain patients have revealed differences in 
the level of this enzyme compared with the cells from normal healthy 
controls. The original investigations with patients with chronic lymphatic 
leukemia showed that the majority of these patients have extremely low 
levels of this enzyme (typically ^  IC^ of the normal values). Later, 
many patients with adult onset hypogammaglobulinaemia were also found to 
have low levels of this enzyme; although the deficiency was generally less 
severe than that observed with chronic lymphatic leukemia. At the time of 
this study, there was a great deal of uncertainty about the relative 5’-N 
activities of the constituent subpopulations of the ‘circulating mononuclear 
cells' under investigation. This was obviously a hinderance to any attempt 
to determine the cause and significance of the low 5'-aucleotidase activity, 
since the relative proportions of the mononuclear cell subpopulations are 
known to differ in these patients.
This thesis describes an investigation of the cause and significance 
of the subnormal ^'-nucleotidase activity found in many patients with 
hypogammaglobulinaemia. In view of the clinical nature of much of this 
thesis, the review of the literature on 5'-nucleotidase (chapter l) includes 
a brief review of the clinical data relevant to the patients investigated. 
The experimental section has been presented in three parts (chapters 2, 3 
and 4), each with its own technical discussion of the results. A general 
discussion comprises the final chapter.
14
CHAPTER 1
A REVIEW OF THE LITERATURE
15
1.1. 5'-nucleotidase (E.c.3.1.3.5.) .
1.1.1. HISTORICAL INTRODUCTION
In 1934, Reis investigated the possibility that the liberation of 
phosphate from nucleotides in cardiac and skeletal muscle may be due to the 
existence of a group of specific nucleotidases rather than non-specific 
phosphatases, Reis prepared crude tissue suspensions of various organs 
from several species and determined the relative rates of phosphate release 
from adenosine 5'-monophosphate (AMP)  ^adenosine 3'-monophosphate (3'-AMP) 
and ^-glycerophosphate at pH 7.0. Bone and kidney suspensions were found 
to liberate phosphate at approximately the same rate from all three substrates, 
However, brain, cardiac muscle, liver and retina suspensions liberated 
phosphate from AMP more readily than from 3'-AÎ'lP and ^-glycerophosphate. 
These results led Reis to postulate the existence of "a phosphatase which 
is specific for the 3'-monophosphate esters of purine ribosides".
1.1.2. DISTRIBUTION OF 5'-NUCLEOTIDASE
5'-Nucleotidase (3*-N) is a widely distributed enzyme. Shortly after 
Reis discovered the enzyme in animal tissue extracts, Gulland & Jackson 
(1938) showed its presence in the venom of many species of snake. In 
1954 Wang reported the presence of 5'-nucleotidase in a soil bacterium, 
and later Kohn & Reis (1963) detected the enzyme in the extracts of many 
bacteria from human sources, A 3'-N has also been isolated and character­
ized from the yeast, Saccharomyces oviformis (Takei, Totsu & Nakanishi,
1969). Plant 3'-ïiucleotidases have been found in extracts of potato 
(Klein, 1937 a» b) and of leaves (Shuster & Kaplan, 1953).
Although the early work of Reis was conducted with simple tissue 
extracts, which rendered much of his data approximate, it appears that the
16
5 ’-N activity per gram wet weight varies considerably for some tissues 
from one species to another (Reis, 194o). For example, when inosine 
5'“monophosphate was used as substrate at pH 7.6, extracts of rat and 
horse hearts showed substantially more 5*-N activity per gram wet weight 
than extracts of hearts from dog, calf, rabbit and pigeon.
Of the components of human peripheral blood, both the serum 
(Dixon & Purdom, 1954) and lymphocytes (Lopes, Nachbar, Zucker-Franklin
6 Siber, 1973) have a readily detectable 5’-N activity. Polymorphonuclear 
leukocytes (Shirley, Wang, De Chatelet & Waite, 1976) and erythrocytes 
lack the enzyme, although erythrocytes have an enzyme which specifically 
hydrolyses pyrimidine 3’-nucleotides (Paglia & Valentine, 1975). In 
contrast, polymorphonuclear leukocytes obtained from guinea pig peritoneal 
exudates were shown to have nearly ten times more 3*-N activity per cell 
than the lymphocytes from the same source (De Pierre & Karnovsky, 1974 b). 
It is not clear whether the difference between human and guinea pig poly­
morphonuclear leukocytes reflects a species difference or the state of 
"activation" of the polymorphonuclear leukocyte.
1.1.3. LOCATION OF 3’-NUCLEOTIDASE IN MAMMALIAN CELLS
Early attempts to determine the intracellular location of 5 ’N 
in rat liver (Novikoff, Podber, Ryan & Noe, 1953; De Lamirande, Allard 
& Cantero, 1958) were limited in success owing to the procedures employed 
to isolate the subcellular organelles. The ultracentrifugal procedures 
employed by these authors were designed to obtain maximal recovery of the 
enzyme rather than, a high degree of purity of the subcellular organelles. 
Consequently, cross-contamination of the cellular fractions gave rise to 
misleading results.
17
Song & Bodansky (1967) employed isolation procedures which, at 
the expense of poor recoveries, resulted in subcellular fractions with 
very little cross contamination. Purification of the nuclear fraction 
was monitored by the determination of DNA-phosphorus and total protein.
They recovered 3^ of the protein and 30^ of the DNA-phosphorus in their 
nuclear fraction. Electron microscopic examination revesiled the absence 
of mitochondria, lysosomes, endoplasmic reticulum and membrane vesicles. 
Recovery of the nuclear marker enzyme, NAD* pyrophosphorylase, was 
with a 16-fold increase in specific activity over the starting homogenate.. 
Recovery of the microsomal marker, glucose-6-phosphatase, was less than 
0.2%,with a ten-fold decrease in specific activity. The removal of 3'-N 
from the nuclear fraction paralleled that of glucose-6-phosphatase, 
indicating that there was little or no 3*-N in the nuclei. A second 
fraction containing both mitochondria and lysosomes was prepared. About 
4o% of the mitochondrial marker, glutamate dehydrogenase, and 3 ^  of the 
lysosomal marker, acid phosphatase, were recovered In this fraction com­
pared with less than 0.6% of the glucose-6-phosphatase and less than 0.4% 
of the 3*-N, These findings suggested that 3*-N was not present in mito­
chondria or lysosomes. Finally, a microsomal fraction was prepared in 
which the recoveries of 3’-N and glucose-6-phosphatase were 23%  and 27% 
respectively. Although this microsomal fraction was slightly contaminated 
with lysosomes and mitochondria and 2% recovery of their respective
marker enzymes), the high and parallel yields of glucose-6-phosphatase 
and 3*-N suggested that both enzymes were exclusively present in the 
microsomes.
The term "microsome" is used to describe the ultracentrifugal 
preparation which consists of plasma membrane and endoplasmic reticulum
18
fragments, with possible contamination from other cell components.
Sucrose density gradient centrifugation of the rat liver microsomal 
fraction revealed that the 5’-N activity resided in the membrane 
fraction of the microsomes rather than the ribosomes (Song & Bodansky,
1967). Further purification of the plasma membrane by Song & Bodansky 
(1967) indicated that most of the microsomal 3"-N was derived from the 
plasma membrane rather than the endoplasmic reticulum.
In 1969» Fritzson partially purified a cytoplasmic 3'-N from rat 
liver. As will be discussed later, this enzjmie had different properties 
to the membrane-bound enzyme. The general properties of Fritzson's 
cytoplasmic enzyme suggested that it was identical to the 3'~N isolated 
from liver acetone powder preparations by Itoh, Mitsui & Tsushima (1968).
As was pointed out by De Pierre & Karnovsky (1973)» the use of 
solid organs, such as liver, for subcellular fractionation studies poses 
problems. Solid organs are generally composed of more than one cell type 
and are vascular, with nerve processes innervating the blood vessels.
With the low yields of plasma membrane generally obtained, there is a 
danger that the preparations may be enriched with material from a minor 
cell type. This problem can be avoided by studying single cell suspensions. 
Subcellular fractionation studies by Bosman, Hagopian & Eylar (1968), 
using HeLa cells, confirmed the findings of Song & Bodansky (1967)» 
showing that 3*-N was located in the plasma membrane. Cytochemical 
studies have also been used to demonstrate the location of 3*-N in the 
plasma membrane of rat lymphocytes (Misra, Gill & Estes, 1974). However, 
the use of cytochemical staining alone to demonstrate the location of 
3'-N should be viewed with caution (De Pierre & Karnovsky, 1973).
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Uusitalo & Karnovsky (l97?a) have used both cytochemical staining and 
biochemical analysis of disrupted cells to demonstrate that 3"-N is 
almost exclusively located in the plasma membrane of mouse lymphocytes* 
Despite the presence of a 3'-N in liver that is not membrane-bound, it 
appears that most of the enzyme in mammalian cells is found in the plasma 
membrane. Indeed, the enzyme is now commonly employed as a plasraa- 
membrane marker (De Pierre V Karnovsky, 1973)*
De Pierre & Karnovsky v1974a) have shown that the active sites 
of membrane-bound 5’-N of the guinea pig polymorphonuclear leukocyte 
face the external medium rather than the cytoplasm. This conclusion was 
derived from three types of experiments. First, the 3'-N activity of 
intact cells was not increased by disruption of the cell membrane which 
acts as a permeability barrier to AMP, Second, the concentration of 
inorganic phosphate produced from AM? by intact cells was shown to be 
100 times greater in the extracellular medium than in the cells. The 
possibility that the substrate was hydrolysed intracellularly, and the 
products transported out, was dismissed by preloading the cells with 
(^^P) phosphate and using (^^P) AMP as substrate. Third, the cells 
were treated with the diazonium salt of sulphanilic acid which cannot 
penetrate intact cells. This treatment rapidly inhibited intact cell 
3’~N activity. These experiments provided strong evidence that 3’-N 
was an "ecto-enzyme".
1.1.4. PURIFICATION AND PROPERTIES OF MAMMALIAN 3'-NUCLEOTIDASE 
Purification
In 1951» Heppel & Hilmoe obtained a 30-fold purification of 3*-N 
from bull seminal plasma. The seminal plasma was first treated with 
protamine sulphate, a polycation which, through its charged groups,
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precipitates polyanions such as nucleic acid proteins. The supernatant 
from the protamine sulphate step was then subjected to two ammonium 
sulphate precipitation steps, followed by two fractionations with ethanol. 
At this stage, Heppel & Hilmoe utilized the stability of the 3*-N to 
remove contaminating non-specific phosphatase activity: the preparation 
was heated to 60^C for twenty minutes and, after rapid cooling, adsorbed 
on aluminium hydroxide gel. The final preparation was free of non-specific 
phosphatase activity and contained 4.1% of the original activity.
A similar procedure was employed by Song and Bodansky (1966) to 
obtain a preparation of 3*-N from human liver that was free of non­
specific phosphatase activity. The location of the in the plasma—
membrane of liver cells necessitated a solubilization step using 3% sodium 
deoxycholate. Otherwise, the procedure was essentially that of Heppel & 
Hilmoe (l95l)* A ten-fold increase in the specific activity was obtained, 
with a yield of 13%.
Two major modifications to the above procedure enabled Widnell 
& Unkeless (1968) to obtain a 5’-N fraction which contained only one major 
lipoprotein. Rather than solubilizing the enzyme from the rat liver 
homogenate, they first isolated plasma-raernbranes; this alone can produce 
a 12-fold increase in specific activity (Song and Bodansky, 196?) although 
the yield may be poor. The solubilized plasma-membranes were fractionated 
with ammonium sulphate, heated to 30°C_for 5 minutes, and refractionated 
with ammonium sulphate. Agarose colutnn chromatography was used for the 
final separation. A more elaborate scheme of column chromatography by 
Nakamura (1976) resulted in purification of 3*-N to a single protein which 
again contained phospholipid. After ammonium sulphate fractionation and
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heat-treatment of solubilized rat liver plasma-membranes, Nakamura 
further purified 5*-N by DEAE-cellulose chromatography and affinity 
column chromatography with 3*-AMP-8epharose.
3'-N was isolated as a single, lipid-free, protein from mouse 
liver plasma-membranes by Evans & Gurd in 1973* These authors used a 
detergent buffer, N-dodecylsarcosinate-Tris, to solubilize the membrane 
proteins which were then fractionated by a rate-zonal centrifugation in 
a sucrose-detergent gradient. The 3'-N activity peak, which was associated 
with 3% of the protein applied to the gradient, was further purified by 
gel filtration on Sepharose and Sephadex columns. The purified enzyme 
was found to be a glycoprotein of molecular weight l40,000 - 150,000, 
which appeared to be composed of two glycoproteins of identical molecular 
weight (70,000 - 73,000). The molecular weight determined for the enzyme 
corresponded closely to the value of l40,000 obtained in the absence of 
detergent with sheep brain 3*~N (Ipata, 1968), and has since been confirmed 
with the plasma membrane enzyme from other sources (Nakamura, 1976;
Dornand, Bonnafous & Mani, 197&)"
Properties of mammalian 3’-nucleotidase
Evans and Gurd (1973) proposed that the lai'ge amounts of sphingo­
myelin which Widnell and Unkeless (1963) obtained with their purified 
enzyme were mainly associated with detergent micelles, and were not the 
result of specific lipid-protein interactions that may occur in the 
intact cell membrane. Addition of pure phospholipids to the 5*-N isolated 
by Evans & Gurd did not increase the specific activity of the enzyme.
This does not, however, rule out the possibility of specific lipid- 
protein interactions in situ, since the added phospholipids may have been 
unable to replace or exchange with the detergent.
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The substrate specificity of the enzyme purified from mouse liver 
membranes by Evans & Gurd is shown in table 1. These results are similar 
to those obtained by other authors for the plasma membrane enzyme 
(Song & Bodansky, 1966; Widnell & Unkeless, I968; Nakamura, 1976;
Dornand, Bonnafous & Mani, 1978). The cytoplasmic 5 ’-N of rat liver 
differs in many respects to the membrane-derived enzyme. Both inosine 
3'-monophosphate (IMP) and deoxy-guanosine 3'-monophosphate (deoxy-GMP) 
are better substrates for the cytoplasmic enzyme than is AMP (table 2),
The Michaelis constant (Km) of the cytoplasmic enzyme for A14P substrate 
is about 6,8 mM (Fritzson, I969), which is more than 100-fold greater 
than the values determined for the membrane enzyme (Song & Bodansky, 196?; 
Widnell & Unkeless, 1968; Evans & Gurd, 1973; Nakamura, 1976). A 3*-N 
has also been partially purified from sheep brain (Ipata, I968) and rat 
heart (Sullivan & Alpers, 1971) using procedures which suggest that the 
enzyme was of cytoplasmic origin. However, the substrate specificity 
and general properties corresponded to those of the membrane-derived 
enzyme. It is therefore tempting to speculate that the 3' -N of the liver 
cytoplasm differs from the enzyme found in the membranes and cytoplasm of 
cells from other tissues, and may perform a function that is unique to 
liver cells.
There is some confusion in the literature regarding the pH optima 
of 3*-N. Generally, it appears that the membrane enzyme has two optima;
one between pH 7*0 - 7»3, and a second between pH 9*0 - 10.0 (Bodansky &
Schwartz, 1963; Song & Bodansky, 1966, 196?; Evans & Gurd, 1973). The 
latter pH optimum is dependent upon the presence of Mg** ions in the assay. 
Apart from the effect of Mg** ions, the choice of buffer has also been
shown to be important (Bodansky & Schwartz, 1963; Burger & Lowenstein,
1970). In particular, glycine inhibits 5'-N below pH 7*3 and activates
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TABLE 1
SUBSTRATE SPECIFICITY OF 3'-NUCLEOTIDASE PURIFIED 
FROM MOUSE LIVER PLASMA MEMBRANES
Substrate Relative Activity
pH 7,6 pH 10,0
Adenosine 3'-monophosphate 100 100
Uridine 3'-monophosphate 103 117
Cytidine 3’-monophosphate 70 6o
Guanosine 3'-monophosphate 88 49
Adenosine 3'-monophosphate 0 n,d.
Adenosine 2'-monophosphate 0 n.d.
Thymidine p-nitrophenyl phosphate 0 15
p-Nitrophenyl phosphate 0 0
Adenosine triphosphate 0 n.d.
Taken from Evans & Gurd (1973). Results are expressed as
a percentage of the specific activity obtained with adenosine 3*-mono 
phosphate as substrate, (n,d, = not determined).
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TABLE 2.
SUBSTRATE SPECIFICITY OF THE CYTOPLASMIC 3*-NUCLEOTIDASE 
PARTIALLY PURIFIED FROM RAT LIVER
Substrate Relative activity at pH 6.5
Ref. (a) Ref. (b)
Inosine 5*-monophosphate 100 100
deoxy-GMP 98 90
Uridine 5’-monophosphate 50 58
Adenosine 5*-monophosphate 5^ 17
deoxy-TMP I6 n.d.
Data taken from: ref. (a), Fritzson (1969); ref. (b), Itoh, 
Mitsui, & Tsushima (1968). Results are expressed as a percentage of 
the specific activity obtained with inosine 5 ’-monophosphate as 
substrate.
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above this pH. The practice of some authors of using different buffer 
systems for a series of points on the same pH profile is therefore open 
to criticism. It is now apparent that this was the reason for Heppel 
& Hilmoe (l95l) observing a single pH optimum at pH 8.0 with bull 
semen plasma 5'-^: Bodansky & Schwartz (I965) and. Levin & Bodansky (1966) 
have since shown that the enzyme from this source has two pH optima.
Not all the discrepancies in the literature may be explained by 
the assay conditions employed. The cytoplasmic 5 ' of liver has a single 
optimum at around pH 6.5 (Itoh, Mitsui and Tsushima, I968; Fritzson, 1969).
A partially purified 5'-N from pig gut has been observed to have three 
pH optima; at 5.5, 7*0 and 8.5 (Burger & Lowenstein, 1970). Although the 
isolation procedure employed by Burger & Lowenstein was such that the 
final enzyme may well have been a mixture of both cytoplasmic and membrane- 
derived 5'“N, this does not seem the likely cause of the optimum at pH 5«5. 
Fox & Marchant (1976) observed a single optimum at pH 9*8 with the 
membrane-bound 5*-N of human placenta in the absence of Mg ions, and 
a broad plateau of activity between pH 7«^ - 9*8 in the presence of Mg^^ions, 
Dornand, Bonnafous & Mani (1978) observed a single optimum at pH 7.5 with 
5*-N purified from pig lymphocyte plasma membrane, regardless of whether 
Mg'*’^  ions were present during the assay. It is interesting to note that 
Dornand et al found the purified enzyme to have a different pH profile 
to that of the enzyme present in intact membranes.
5‘~N appears to be a Mg -dependent enzyme. The cytoplasmic enzyme 
of rat liver is completely inactive in the absence of divalent cations, of 
which is the most effective activator but Ca'^\has no effect
(Itoh et al, 1968)0 The enzyme from other sources appears to have a tightly 
bound divalent ion; no additional Mg^^ is necessary for activity at
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pK 7.4, but EDTA reversibly inhibits the enzyme (Emmelot & Bos, I966; 
Sullivan & Alpers, 1971» Dornand, Bonnafous & Mani, 1978). Mg** and 
Mn** ions proved to be the most effective at reversing the inhibition 
of EDTA, The second, alkaline, pH optimum reported for is
dependent upon the presence of Mg** even in the absence of EDTA (Song 
8c Bodansky, 1966, 1967; Evans & Gurd, 1975)* Mg** ions have also been 
shown to reverse the inhibition of 5'-N by AD? and ATP (Burger & Lowenstein, 
I97O; Sullivan & Alpers, 1971)*
Nucleoside di- and tri- phosphates are competetive inhibitors of 
5'-N activity; the diphosphates being the more powerful inhibitors 
(Burger & Lowenstein, 1970; Sullivan & Alpers, 1971; Nakamura, 1976;
Rodan, Bourret & Cutler, 1977; Dornand, Bonnafous & Mani, 1978). The 
phosphonate analogue of ADP, ct ^ -methylene adenosine diphosphate (AOPCP), 
is an even more potent inhibitor of the enzyme (Burger & Lowenstein,
1970, 1975)* Ipata (1968) reported that a 5’-N partially purified from 
sheep brain was allosterically inhibited by ATP. However, no other 
reports of sigmoidal inhibition curves are l-oiown; indeed. Burger &
Lowenstein (1975) were unable to reproduce the work of Ipata,
1.1.5* THE ASSAY OF 5 '-NUCLEOTIDASE ACTIVITY
Until recently, 5 ’-N activity was commonly measured by the calori- C 
metric determination of inorganic phosphate (Pi) released from the nucleo­
tide substrate. This procedure does not allow the inclusion of competetive 
inhibitors of non-specific phosphatase activity, such as Ç -glycero­
phosphate or 5'-AMP, in the assay. Consequently, the contribution of non­
specific phosphatases to the breakdown of the 5'-nionopho3phates must be 
determined in a separate assay (eg: Reis, 1954; Dixon & Purdom, 1954).
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Ipata (1967, 1968) employed a quicker procedure which involved coupling 
the 5*“N to the deamination of adenosine, by the presence of excess 
adenosine deaminase, and following the reaction spectrophotometrically 
at 265 nm. In this system, ^  -glycerophosphate may be added to inhibit 
non-specific alkaline phosphatase activity (Belfield & Goldberg, I96S).
The above methods are laborious and prompted the development of 
radiometric procedures which were quicker and more sensitive. Thin- 
layer chromatography (Shenoy & Clifford, 1975), high-voltage electro­
phoresis (Fox & Marchant, 1976; Webster et al, 1978) and ion-exchange 
chromotography (Chatterjee, Bhattacharya & Barlow, 1979) have been employed 
to separate the products of the reaction from the substrate.
Adsorption of unreacted ^^P-labelled AMP onto Norit A (Quagliata, Faig, 
Conklyn & Silber, 197^) or onto charcoal (Be Pierre & Karnovsky, 1974a) 
also allows a quick and sensitive assay, but suffers a serious limitation
in that the has a short half-life of only l4 days. Methods which 
iL 3
employ G or H labelled substrate do not have this drawback. The 
procedure used in this thesis was based on that described by Avruch & 
Wallach (l97l) in which ZnSO^ - BaCOH)^ was used to quantitatively pre­
cipitate AMP, leaving adenosine in solution.
5'-N may also be assayed by using histochemical methods based on 
that developed for the demonstration of phosphatase activity in tissue 
sections (Gomori, 1959). This system locates the site of enzyme activity 
by precipitation of the Pi reaction product with metal ions. Usually, 
lead ions are used and the precipitate is converted to brown lead sulphide 
for visualization by light microscopy, although the system can be adapted 
for electronmicroscopy. Histochemical assays for 5*-N have been employed 
in the investigation of the enzyme on human lymphocytes (Muller-Hermelink, 
1974; Silber, Conklyn, Grusky & Sucker-Franklin, 1975).
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While the histochemical assays have proved useful in the studies 
of lymphocyte 5'-N, the limitations and drawbacks should be appreciated.
The formation of a lead precipitate at the site of reaction is dependent 
upon the rate of production of Pi, and the efficiency of the trapping of 
the Pi by the lead ions. De Jong, Hak, Van. Duijn & Daems (1979) used a 
model system to show that the trapping efficiency was reduced by a number 
of factors commonly present in the media employed in many assay systems.
By taking into account the rate of enzyme reaction in various incubation 
media, together with the trapping efficiency. De Jong et al were able to 
modify the conditions to obtain more than double the percentage of cells 
staining positively for acid phosphatase than when using the media employed - 
by other workers. The same principles are applicable to the histochemical 
determination of 5'-N. It is therefore apparent that the 'threshold* for 
the positive demonstration of enzyme activity in a cell is dependent on 
the composition of the incubation medium. This should be taken into 
consideration when attempting to define subpopulations that are 'positive* 
or 'negative* for When using the histochemical assay for determination
of the cellular location of 5'-N (eg, Hisra, Gill & Estes, 1974) one 
should also consider the possibility that the lead precipitate may not be 
located at the site of the enzyme.
1.1.6. MECHANISM OF 5'-NUCLEOTIDASE ACTIVITY
Site of cleavage of substrate
By studying the hydrolysis of A>î? by bull semen plasma 
5'-N in the presence of H^O^^, Koshland & Springhom (1956) showed that the 
phosphate was liberated by cleavage of the P-0 rather than the C-0 bond;
Ad-0 PO^ + H^O^G -----------} Ad-OH + EO^^PO
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Mechanism of 5*-nucleotidase activity
Little is known about the mechanism of 5*-N activity although Levin 
& Bodansky (i960) postulated a model that was consistent with their 
findings regarding the effect of Mg** ions and pH. They proposed that 
5'-N has four sites relevant to its catalytic activity (see Fig. 1).
The binding sites for the nucleotide and H^O are denoted by X and W 
respectively. Site Y is a cationic binding site; at low pH values it is 
designated Y-H*, and at alkaline pH it is converted to Y which allows 
combination with Mg**, The fourth relevant to proposed mechanism is 
designated Z,. and the active form of this site is Z-H*, which binds the 
phosphate moiety of the nucleotide substrate.
They proposed that Z-H*binds with the phosphate moiety of the 
substrate molecule; which induces a positive charge on the phosphorus 
atom and facilitates attack by the hydroxyl ion present at the water- 
binding site, W, As the pH is raised, Z-H* is inactivated. In the 
presence of Mg**, raising the pH results in replacement of H* with Mg** 
at the electronegative site, Y. The Y-Mg** complex then binds with the 
phosphate. This makes the phosphate moiety more electrophilic and thus 
more susceptible to interaction with the hydroxyl ion at site W. This 
model offers a plausible explanation for the double pH optimum of 5 ’-N .
1.1.7 THE PHYSIOLOGICAL FUNCTION OF ^'-NUCLEOTIDASE
The role of 5’-N is unclear. At least four important enzymes in 
the glycolytic pathway and citric acid cycle are influenced by the 
concentration of AMP (Atkinson, I966), The 'adenylate control hypothesis' 
thus proposes that glycogen phosphorylase, phosphofructokinase , 
fructose-1, 6- diphosphatase, and isocitrate dehydrogenase may be under
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Figure 1
MECHANISM OF 5'-NUCLEOTIDASE ACTIVITY
Proposed mode! for the effect of on the hydrolysis of AMP by 
5'-Nucleotidase ( from Levin & Bodansky, 1966)
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w water-binding site 
X ribose-binding site 
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z phosphate-binding site
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the influence of 5*-N activity. More recently. Arch & Newsholme (1978) 
reviewed the evidence for a hormonal role of adenosine, and the potentially 
important role of in regulating the concentration of adenosine. These
authors considered that the ability of Mg’*”*' to relieve the inhibition of 
5’-N by ADP and ATP was important for the regulation of the enzyme in situ.
The regulatory function of mentioned above may well be of
importance for the cytoplasmic enzyme but the role of the ecto-enzyme 
remains enigmatic. It has been proposed that the function of human lympho­
cyte ecto-5’-N is the salvage of purines, from AMP (Jleit, Conklyn, Stebbins 
& Silber, 1975)» The cell membrane is impermeable to nucleotides but 
permeable to nucleosides; thus the enzyme may facilitate the uptake of 
purines from nucleotides in the extracellular mediuja. However, as pointed 
out by the authors themselves, it remains uncertain whether an absence of 
ecto-5'-N presents a physiological disadvantage to the cell in vivo, since 
phosphatases (and 5'-N) in the surrounding environment would cleave the 
nucleotides and make the nucleoside available to the cell,
5*-N has been reported to reverse the inhibitory action of actin on 
deoxyribonuclease by interacting with actin (Mannherz & Rohr, 1978). In 
this respect, it is interesting that actin has been reported on the surface 
of lymphocytes, and mainly on B-lymphocytes (Owen et al, 1978), However, 
the significance of these observations in relation to the function of 5'-N 
is not known,
Cohn & Parks (1967) found that high concentrations of AMP, ADP^ATP 
and to a lesser extent, adenosine, induced the formation of large numbers 
of vesicles in mouse macrophages, while other nucleotides and related 
nucleosides had little or no effect. This stimulation of pinocytosis was 
later observed.to be paralleled by a dramatic increase in ecto-5 ’-M activity 
(Lazdins & Karnovsky, I978). If this increase in activity were to
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result in an increase in the intracellular nucleoside and nucleotide 
pools, there may well be an increase in the cell metabolism. Cohn & Parks 
(1967) raised the question of whether such an increase in cell metabolism, 
might cause the cell to respond more vigorously to an external stimulus 
( the response being pinocytosis),
1.1.8. LYMPHOCYTE 3»-NUCLEOTIDASS
Normal human lymphocytes have a readily detectable 5’-N activity 
(Lopes, Nachbar, Zucker-Franklin &.Silber, 1975). The enzyme is located 
in the plasma membrane and the observation that Concanavalin A, which 
binds to cell surface glycoproteins, inhibits up to 9C^ of the 5'-^ 
activity of lymphocytes (Webster et al, 1978) is compatible with the 
cell-surface location of the enzyme. Although Muller-Hermelink (197^) 
showed that B-cell regions of lymphatic tissue sections stained positively 
for activity, while the T-csll regions were negative, other workers,
have failed to demonstrate a significant difference between the level of 
3 ’-N activity on B- and T- cells (Quagliata et al, 197^; Kramers et al,
1976; Edvards, Hagilavy, Cassidy & Fox, I978).
That nvany, but not all, patients wich chronic lymphatic leukemia 
(CLL) have markedly reduced levels of 5'-N on their circulating lymphocytes 
is now well documented (Lopes, Zucker-Franklin & Silber, 1973; Marique & 
Hildebrand, 1973; Quagliata et al, 197^; Kramers et al, 1976; La Mantia,. 
Conklyn, Quagliata & Silber, 1977; Kanter, Freiberger, Rai & Sawitsky, 1979) 
A minority of CLL patients bave supranormal levels of 5'-^ activity 
(Quagliata et al, 197^; La Mantia- et al, 1977; Kanter et al, 1979). Cord 
blood lymphocytes were reported to have less 5'-N activity than the blood 
lymphocytes from healthy adults (Kramers, Catovsky, Cherchi & Galton, 1977).
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The circulating mononuclear cells of patients in the early stages of 
infectious mononucleosis also have a low level of activity, but
otherwise the 5’-N activity has been shown to be unaffected in a number 
of cardiopulmonary, metabolic, neoplastic, dermatological, and infectious 
disorders (Quagliata et al, 19?4).
Soon after the discovery that certain immunodeficiency diseases 
were associated with defects of purine metabolism (see 1.2.6.), Johnson 
et al (1977) reported that many patients with late onset 'common-variable' . 
hypogammaglobulinaemia (CV-H) have low levels of on their circulating
mononuclear cells. This led to the report that patients with X-linked 
hypogammaglobulinaemia (X-H) had activities at the lower limit of
the normal range, and that three patients with selective IgA-deficiency 
had barely detectable $'-N activity (Webster et al 1978). A number of 
other enzymes involved in purine metabolism were found to have normal 
activity in patients with hypogammaglobulinaemia (Webster et al, 1978).
A group of American workers have obtained different results with their 
patients. They reported that their group of X-H patients had a lower 5'-# 
activity than the patients studied by Webster et al, and that their CV-H 
patients had an apparently normal range of activity, as did their
patients with IgA-deficiency (Edwards et al, 1978).
The primary aim of the work presented in this thesis was to 
investigate the cause and significance of low activity in patients
with hypogammaglobulinaemia. In order to gain an understanding of why 
certain lines of thought were pursued, there follows a brief review of the 
type of patients studied and the association of defects of purine metabolism 
with certain immunodeficiency diseases.
34
1.2. PRIMARY IMMUNODEFICIENCY
1.2.1. INTRODUCTION
Immunological responses are classically divided into 'humoral* 
and 'cell-mediated' type responses; both of which are lymphocyte- 
dependent. B-lymphocytes, with the help of T-cells, are responsible 
for the synthesis and secretion of free antibody into the blood and other 
body fluids (humoral antibody), while the T-lymphocytes are the mediators 
of specific cellular immunity.
Historically, X-linked hypogammaglobulinaemia (X-H) was the first 
type of immunodeficiency to be recognized (Bruton, 1952). This condition 
represents a pure B-cell defect, with impairment of antibody and immuno­
globulin synthesis (i.e. the humoral response). The DiGeorge syndrome 
(DiGeorge, 1965, 1968), in which the cell-mediated response is undetectable, 
represents a pure T-cell defect. Although a humoral response can be 
elicted in the DiGeorge syndrome, it is subnormal since the B-cells require 
the co-operation of T-cells. Severe combined immunodeficiency (SCID) 
arises from the failure of both B- and T- cells to develop normally, with 
a consequent loss of both humoral and cell-mediated immunity. The three 
aforementioned types of immunodeficiency are the most clear-cut, and also 
rare, examples recognized. The majority of immunodeficient patients defy 
such clear-cut classification and are grouped under the heading of 'common- 
variable' immunodeficiency,
1.2.2. X-LINKSD HYPCGAMH4GL0BULINAHMLA
Patients with X-H have a defect of humoral immunity and are subject 
to recurrent bacterial infections. They handle most viral infections 
normally, although they are prone to Echovirus infection which produces a
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mild self-limiting illness in normal individuals but is usually fatal 
in patients with X-H (Wilfert, 1977)- Respiratory symptoms nearly always j
k
present in the first two years of life, and usually after the first two 
months. Antibodies passively transferred in utero probably provide 
adequate protection in the first few months of life.
The disease is characterised by low levels of all classes of 
immunoglobulin in the serum. Fr^land & Natvig (1972) first observed that 
these patients lacked circulating B-cells, but it is now clear that some 
patients may have small numbers of these cells (Geha, Rosen & Merler, 1973; 
Schwaber, Lazarus & Rosen, 1978). Although it is possible that these 
patients have B-cells that differ from normal in that they lack surface 
immunoglobulin, a number of studies suggest that this is unlikely to be 
the case. Hoffman et al (1977) showed that X-H patients lack lymphocytes 
with another B-cell marker, la-type antigen, on their surface. Geha,
Rosen & Merler (1973) demonstrated a lack of cells with the density of 
B-cells in the blood of these patients. Finally, Wiig (1973) showed that 
cells with the electrophoretic mobility of B-cells were missing.
The none marrow of X-H patients contains normal numbers of pre-B 
cells, although their rate of division is reduced (Vogler et rlL, 1976,
Pearl et al, 1978). The presence of pre-B cells and the low, but definite, 
level of serum immunoglobulin in patients with X-H suggest that the 
disease is not due to a severe defect in the structural gene for immuno­
globulin. It is possible that there is a maturation arrest at the 
pre-B stage.
These patients appear to have normal T-cells and normal cell-mediated 
imorinity. The blastogénie response to Phytohaemagglutinin (PHA) and antigens 
is normal (Gotoff, I968). In addition, the total numbers of T-cells are
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normal, as is the proportion with receptors for IgM and IgG (Moretta et al, 
1977; Gupta & Good, 1977)-
Inheritance is of the classical sex-linked type in'v/hich the 
'carrier' female has one normal X-chromosome and one containing the 
defective allele. Thus, the affected males have the defective gene on 
their single X-chromosome, Of the patients' offspring, the sons will 
be normal but the daughters become 'carriers'. Owing to the small sizes 
of families, diagnosis of the disease is often uncertain; but it is highly 
probable when there are affected brothers, and almost certain when there 
is an affected maternal uncle.
Treatment of these patients involves regular injections of gamma­
globulin, which helps to prevent serious bacterial infections. Provided 
that these patients receive regular medical care, with early treatment 
of any infections, their prognosis is reasonable.
1.2.3. SEVERE COMBINED IMMUNODEFICIENCY
Although no patients with this syndrome were studied in this thesis, 
they are of interest because of the association with defects of purine 
metabolism (see 1.2.6.). They have a severe defect of both cellular and 
humoral immunity, and suffer recurrent bacterial, viral, and fungal 
infections. SCID characteristically presents in the first three months of 
life and is fatal if untreated. The syndrome may show autosomal recessive 
or X-linked inheritance, or may occur sporadically.
Lymphopenia is a common feature of this disease, but the number of 
B-cells is often normal or raised (Siegal & Good, 1977)» The classes of 
immunoglobulin on the B-cells of these patients may be unusual (Preud*homme, 
Clauvel & Seligmann,1973) and antibody production is invariably lacking.
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Until recently, the cause of SCID was believed to be a stern cell defect 
in the bone marrow that prevented the natural differentiation into B- and 
T- cells. However, since most patients are observed to have some B-cells 
in their blood, this is unlikely to be a common cause of the disease. The 
discovery that a deficiency of the enzyme, adenosine deaminase (ADA), is 
the cause of the disease in a number of SCID patients (see 1.2.6. ) has 
strengthened the belief that a biochemical abnormality may be interfering 
with the maturation of both B- and T- cells.
1.2.4. SELECTIVE IgA-DEFICIENCY
Severe IgA-deficiency in the serum is puzzling in that it has a 
relatively high incidence of about I/7OO among the healthy population of 
many European communities (Koistinen, 1975; Holt, Tandy & Anstee, 1977)*
The role of IgA is uncertain. Since IgA is the major immunoglobulin on 
mucosal surfaces, measurement of IgA levels in mucosal secretions may be 
more relevant than serum IgA levels. However, with the rare exceptions, 
severe deficiency of serum IgA is paralleled by a deficiency of secretory 
IgA (Goldberg, Douglas & Fudenberg, 19&9; Cassidy, Oldham & Platts-Mills,
1979)* Respiratory infections and autoimmune-diseases are found in a 
number of patients with severe IgA-deficiency (Amman & Hong, 1971)*
However, because of the high incidence of IgA-deficiency among the healthy 
population, and the problems arising from the selection of patients in a 
hospital series, it is difficult to assess the association between IgA- 
deficiency and disease.
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A deficiency of IgA does not appear to be crucial in Europeans, 
but the rarity of this immunoglobulin deficiency among Africans (Lawton, 
Royal, Self & Cooper, 1972) suggests that it may be necessary for survival 
in adverse conditions. It appears that although IgA may provide an 
important defence against bacterial infection, its absence is usually 
compensated for by an increased efficiency of one or more of the other 
components of the immune system. The replacement of IgA by IgM in 
secretions may be important in preventing infection, although respiratory 
infections have been observed in an IgA-deficient patient with adequate 
compensatory IgM (personal communication, A.D.B. Webster).
Patients with severe IgA-deficiency appear to have normal functional 
T-cells. In particular, the T-cells provide normal 'help* for the 
production of IgA by normal. B-cells (Cassidy, Oldham & Platts-Mills, 1979)*
In contrast, the B-cells of these patients fail to synthesize IgA even 
when separated from their own T-cells and provided with normal T-cell 
help. Synthesis of IgM by the B-cells of these patients is normal, but 
IgG synthesis is sometimes subnormal.
1.2.5. ‘ COÎfMON-VARIABLE' HYPOGAMMAGLOBULINAEMIA
Patients with CV-H are usually grouped into childhood- or adult- 
onset CV-H, depending on whether the onset of sjimptoms occurred before 
or after the patients sixteenth birthday. This avoids the possibility of 
including any X-H patients in the adult-onset group. However, the two 
groups of C/-H patients are very similar clinically (Asherson & Webster,
1980). The majority of CV-H patients develop their disease in the third 
decade. In common with X-H patients, CV-H patients suffer recurrent respira­
tory infections and handle most viral infections normally. However, they differ
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from the X-H patients in that they tend to develop a number of unusual 
complications such as polyarthritis and autoimmune disease. Most 
patients with CV-H respond well to weekly injections of gammaglobulins 
and treatment with antibiotics.
The number of T-cells is normal in CV-H patients, but about a 
third of the patients show a T-cell defect as indicated by a negative 
delayed hypersensitivity skin test and a poor in vitro response to PHA 
(Webster & Asherson, 1974). However, these patients do not suffer more 
infections than those with normal T-cell function; which renders the 
relevance of these tests to the in vivo function of the cells questionable. 
Suppressor T-cells are present in some patients, although patients with 
suppressor T-cells normally lack circulating B-lymphocytes (de Cast et al, 
1979). The significance of suppressor T-cells in CV-H is therefore unclear. 
Circulating B-lymphocytes are absent in about a quarter of CV-H patients, 
and low in a further quarter (Preud'homme, Griscelli & Seligmann, 1973;
Horwitz, Webster & Newton, 1977). When present, they consistently show 
poor immunoglobulin in response to the in vitro stimulation with Pokeweed 
mitogen (PV/M), even when provided with normal T-cell help (De la Concha 
et al, 1977).
With the majority of patients with CV-H there is no convincing 
evidence for a hereditary basis to the disease. However, Freidman et al (1977) 
have shown an increased incidence of autoimmune phenomena in relatives 
of patients with CV-H. It is therefore possible that some cases of 
CV-H may arise from environmental influences on a predisposing genetic 
background.
1.2.6. ENZYME DEFECTS IN IMMUNODEFICIENCY DISEASE
1.2.6.1. Introduction.
The discovery of two unrelated children with SCID who lacked ADA 
activity in their erythrocytes (Giblett et al, 1972) provided the first 
clue that a biochemical defect may be responsible for an immunodeficiency 
disease. Shortly after this discovery, Giblett et al (1975) reported a 
deficiency of the enzyme, purine nucleoside phospîiorylase (PNP), in a 
child with a predominant T-cell defect. Both these enzymes are components 
of the purine interconversion pathway (Fig. 2).
1.2.6.2. Adenosine deaminase deficiency
ADA catalyses the conversion of adenosine or deoxyadenosine to inosine 
or deoxyinosine respectively, and is present in most tissues of the body. 
Parkman et al,(1975) presented evidence suggesting that ADA-deficiency 
is transmitted as an autosomal Mendelian trait. Thus homozygosity of a 
'silent? gens for ADA causes a severe deficiency of the enzyme. Clinically, 
SCID patients lacking ADA resemble those with the enzyme (Meuwissen, Pollara, 
& Pickering, 1975).
The consequences of ADA-deficiency are uncleai'. Green & Chan (1973) 
suggested that cell proliferation was inhibited as a result of an increase 
in the intracellular concentration of adenosine, which ultimately leads to • 
pyrimidine starvation. V/olberg et al (1975) proposed that ADA-deficiency 
resulted in elevated levels of cyclic-AMP, which m.ay have a more direct 
suppressive effect on the immune-function of lymphocytes. A more recent 
view is that the accummulation of the toxic metabolite, deoxy-ATP, is . 
responsible for the loss of lymphocyte function in ADA-deficient patients.
Ficure 2
PURXI'JE INTERCOM VERSION PATHWAYS
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Deoxy-adenosine has been found in raised concentrations in the urine 
of these patients (Sicimonds, Sahota^ Potter & Cameron, 1978), and such 
concentrations of this nucleoside inhibit the in vitro blast-transformation 
of normal lymphocytes in the presence of an inhibitor of ADA (Simmonds,
Panayi & Corrigall, 1978). The absence of ADA in lymphocytes results 
in the conversion of deoxy-adenosine to deoxy-ATP by a purine kinase 
(Carson, Kaye & Seegmiller, 1977). High concentrations of deoxy-ATP have 
now been demonstrated in the lymphocytes of ADA-deficient patients (Cohen, 
Ullman, Gudas & Martin, 1979) and it has been suggested that the toxicity 
of this metabolite is due to the fact that it inhibits the enzyme, 
ribonucleotide reductase, which may be important in controlling DNA synthesis,
Although bone marrow transplants remain the only current cure for 
SCID, enzyme replacement therapy has proved successful for treating a 
number of ADA-deficient patients (Polraar, 1979)* Transfusion of red 
cells, which contain ADA and have a half-life of about four weeks, causes 
an increase in the number of circulating T-cells and a restoration of 
blast transformation response to PHA, The lymphocyte ADA activity does 
not increase, and the treatment probably works by reducing the concentration 
of toxic metabolites in the serum,
1.2.6.3, Purine nucleoside phosuhorylase deficiency
Pl'iP catalyses the conversion of inosine or guanosine to their 
corresponding bases. No corresponding enzyme has been found to convert 
adenosine to adenine in human tissues, A deficiency of PNP has been 
reported in seven children from four families (Giblett et al, 1975;
Stoop et al, 1977; Biggar et al, 1978 ; Virelizier et al, 1978). A U
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these patients had defective T-cell function but normal, or raised levels 
of serum immunoglobulin. This is in contrast to ADA-deficiency which 
affects both T« and B-cell function. Plasma and urinary* concentrations 
of inosine, deoxy-inosine, guanosine and deoxy-guanosine were found to be 
raised in PNP-deficient patients (Stoop et al, 1977; Simmonds, Sahota,
Potter & Cameron, 1978). Cohen et al (1979) have also reported a ten-fold 
increase in the concentration of deoxy-GTP in the lymphocytes of these 
patients. The biochemical consequences of PNP-deficiency are probably 
similar to those of ADA-deficiency except that deoxy-GTP is the likely 
toxic metabolite. Red cell transfusions have been successful in correcting 
the immunological defects of one PNP-deficient patient (Zegers et al, 1979)»
1.3. CHRONIC LYMPHATIC lEUKEMLA
CLL is a malignant blood disease that occurs late in life (9C^ of 
the patients being above the age of pO) and the essential criterion for 
diagnosis is a sustained lymphocytosis in which the malignant cells are 
of monoclonal origin. Although T-cell CLL occasionally occurs, in the 
vast majority of patients there is an accimulation of B-lymphocytes. The 
absolute numbers of T-cells usually remains unchanged, although they are 
considerably diluted by the large excess of B-cells. At present there 
is no cure for CLL and treatment is largely symptomatic. In practice, 
many patients require no treatment at all,
CLL has been described as the accumulation of immunologically 
incompetent cells (Dameshek, 196?). In keeping with this view, both humoral 
and cellular immunity are impaired, and this secondary immunodeficiency
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may manifest itself by a marked susceptibility to recurrent infections.
The monoclonal origin of leukemic lymphocytes has been demonstrated 
by the observation that these cells express surface immunoglobulin with 
a. single light chain type (Grey, Rabellino, & Pirofsky, 1971; Wilson 
& Nossal, 1971). The density of immunoglobulin on leukemic B-cells is 
generally lower than normal (Theil, Dormer & Eulitz, 1975) and they are 
thought to be arrested at an early stage of differentiation (Salmon & 
Seligmann,1974).
A method of clinical staging of the disease has been proposed which 
is based on the concept that CLL is a disease of progressive accumulation 
of non-functional lymphocytes (Rai et al, 1975). Attempts to correlate 
the 5’-N activity of CLL lymphocytes (see 1.1.8.) with the clinical 
stage of the disease (Kanter et al, 1979) and with the numbers of B- and 
T- lymphocytes (Quagliata et al, 1974; Kanter et al, 1979) have proved 
unsuccessful. Kanter et al did report an apparent correlation between 
the activity of CLL lymphocytes and their in vitro blastogénie
response to mitogens. They found that those patients with a normal 
activity tended to show a better response to PHA than the patients with 
low or supranormal levels of However, the group of patients with
normal $'-H activity showed the least severe lymphocytosis, and would 
therefore be expected to contain a higher proportion of non-malignant 
cells.
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CHAPTER 2
THE ROUTINE DETERMINATION OF THE 3»-NUCLEOTIDASE ACTIVITY OF 
CIRCULATING MONONUCLEAR CELLS ; THE DEVELOPMENT AND 
APPLICATION OF A SUITABLE ASSAY.
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2.1. INTRODUCTION
The assay used for the determination of activity in these
studies was based on the radiometric procedure employed by Avruch & 
Wallach (l97l) for the study of rat fat cell Because this
assay was not specifically designed for the determination of human 
lymphocyte ecto-5'~N activity, a reassessment of the optimum conditions 
was undertaken. The inclusion of ^  -glycerophosphate (Belfield & 
Goldberg, I968) and L (+) tartrate (King & Jegatheesan, 1959) as 
inhibitors of non-specific phosphatase activity was considered in order 
to improve the specificity of the assay. The validity of objections 
raised against this type of assay (Chatterjee, Bhattacharya & Barlow, 
1979) was also tested. Using a suitably modified assay, previous 
studies with CLL and hypogammaglobulinaeraic patients were repeated.
These results are discussed in relation to the apparent discrepancies 
between the results of Edwards et al (1978) and Webster et al (1978).
The parents of some CV-H and X-H patients were also studied for evidence
of a hereditary basis to the low 5*-N activity.
For convenience, the results in this chapter have been divided 
into two sections and discussed separately : the results of the 
investigation of the assay conditions are discussed before the 
presentation of the results obtained with the patients.
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2.2. M/iTEPJALS & METHODS
2.2.1. Materials
Chemicals were obtained from the sources listed.
Adenosine
2-(^H)-Adenosine
Adenosine ^'-monophosphate (Al'lP)
2-(^H)-AMP
p-Bis 2-(p-phenyloxazolyl)-benzene
(POPOP)
2,5 Diphenyloxazole (PPO)
Ficoll Ago 
^ -Glycerophosphate 
Glycine 
Isoton
Sodium barbitone 
Sodium cacodylate 
Sodium potassium (+) tartrate 
Triosil 44o
Tris (hydroxymethyl) methylamine
(tris)
Zaponin
SIGMA
RADIOCHEMICAL CENTRE, AMERSHAM 
SIGMA
RADIOCHEMICAL CENTRE, AMERSHAM
NUCLEAR ENTERPRISES LTD. 
NUCLEAR E23TERPRISES LTD. 
PHARMACIA 
SIGMA
BDH
COULTER ELECTRONICS LTD.
BDH
BDH
BDH
NTEGAARD & CO., OSLO 
BDH .
COULTER ELECTRONICS LTD.
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2.2.2» Isolation of -peripheral blood mononuclear cells
Mononuclear cells were isolated from fresh defibrinated peripheral 
blood by Ficoll-Triosil density gradient separation (Bbyum, I968). 
Ficoll-Triosil, of specific gravity 1,077, was prepared from; 96 ml 
of 9% (wt/vol) Ficoll 400, 20 ml Triosil 44o, and 20 ml H^O. The 
solution was sterilised and stored in the dark at room temperature. Up 
to 15 ml of blood was layered onto 10 ml of Ficoll-Triosil, and 
centrifuged for 15 rain at 1200g. Mononuclear cells were harvested from 
the gradient interface and washed (10 min at 200g) three times in 
isotonic 10 raM tris-buffered saline, pH 7*5 2o°C yield of
mononuclear cells was usually between 0.5 - 1.0 x 10^ cells per ml of 
normal blood.
2.2.3. Isolation of peripheral blood nolymornhonuc?.ear leukocytes
Fresh defibrinated blood was separated on a Ficoll-Triosil 
gradient as in 2.2.2., and the polymorphonuclear leukocytes recovered 
from the gradient pellet. The pellet was washed in TBS and then 
subjected to ammonium chloride lysis to remove the erythrocytes 
(Beyle, 1968). The washed cell pellet was resuspended in isotonic 
0.l4 M NH^Cl^ solution buffered with 0,017 H tris-HCl, pH 7»52o°c* 
which hod been preheated to 37^C, After 5 rain incubation at 37°C, 
the cells were washed twice in TBS at room temperature. A differential 
cell count was performed in order to determine the extent of con­
tamination by mononuclear cells (usually less than ^).
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2.2.4. Isolation of tonsil lymphocyte plasma membranes
Human tonsils obtained within 2 hr of surgical removel provided 
a convenient source of large numbers of viable lymphocytes. Between 
2 - 10 X 10^ lymphocytes were obtained from each pair of tonsils.
The tonsils were gently teased in calcium- and magnesium- free 
Dulbecco's phosphate-buffered saline (PBo) (Dulbecco & Vogt, 1954) 
and filtered through nylon gauze to remove clumps of tissue. Erythro­
cytes and some non-lymphoid cells were removed by Eicoll-Triosil 
density gradient centrifugation (2.2.2.). The mononuclear cells
n
were washed three times in PBS and resuspended to about 2 x 10 cells/ml 
in ice-cold PBS. This cell-suspension usually contained greater than 
9^0 lymphocytes, of which more than 90^ were viable as shown by 
trypan blue dye exclusion.
The cells were disrupted at 0°C by pumping the suspension 
through a cell disruption pump at 400 ml/hr (Wright, Edwards & Jones,
19?4). This ruptured the cells, but not the subcellular particles, 
by forcing the suspension through a small oriface against a spring- 
loaded valve at a pressure of about 28 kg/cm • The disrupted cell 
suspension was then subjected to the differential centrifugal scheme 
shown in fig 5 (Allan & Crumpton, 1970). When the membranes were not 
used immediately, they were resuspended in 0.29 M sucrose buffered with 
10 mH tris-HCl, pH 7 = 5 stored at -70°C.
Figure 3
SCHEME FOR THE ISOLATION OF MEMBRANES FROM LYMPHOCYTE 
CELL SUSPENSIONS
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20 X  10^ cells/ml in TBS at 0°C
disrupted in cell pump. Centrifuged
at 300g, . for 15 min.(av)
Pellet
cells, Nuclei )
Pellet
(  î v I i t o G h o n d r ia , Lysosomes )
Pellet 
( MEMBRANES )
Washed in hypotonic 10 mM tris-
20 C
Centrifuged at 4000g 
for 15 min.
(av)
Centrifuged at 20000g 
for 30 min.
(av)
Supernatant
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2.2.3* The 3'-nucleotidase assay
For the routine determination of 3'-^ activity, the following 
stock solution was prepared and stored at -20°C until required:
0.04 mM AMP, with 0.4 jxC±/ml tracer 2-(^H)~AMP 
0.12 mM ^-glycerophosphate 
20 mM NgCl
200 mM glycine-NaOH buffer, pH 8.3
Between 10^ - 10^ cells in TBS were mixed with an equal volume of the 
stock substrate solution, and incubated at 37°C for 20 min. The 
reaction was terminated by transferring the assay tubes to an ice 
bath and adding 0.3 ml of 0.123 M ZnSO^ solution (which inhibits 3'-M 
activity). Unreacted AMP was precipitated by the addition of 1.0 ml 
of BaCOH)^ solution, and removed by centrifugation at 2000g for 3 min.
One ml aliquots of the supsrnatents were coionted for tritium in 
9.0 ml of xylene-Triton scintillation fluid (13 g PPO, 0.3 g FOPOP,
2.3 1 xylene, 1.23 1 Triton X-100, 375 ml methanol).
All determinations were performed in duplicate, and background 
counts were determined from blanks in which 0*3 ml of TBS was added in 
place of the cell suspension. Standards were prepared by diluting 0.5 ml 
of the stock substrate solution with 1.8 ml of TBS, and counting 1.0 ml 
aliquots. The enzyme activity was expressed in units of : nmol AMP 
hydrolysed/hr/lO cells. The following expression was used to determine 
the 3'-M activity:
(X _ B). 6 r
3 ’-N activity =     x 10
(S - B). N
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where ; X = c.p.m. of sample 
B = c.p.m. of blank 
S = c.p.m. of standard 
N = number of cells present in sample
The cell concentrations for the assay were determined electronically 
using a Coulter Counter (see 2.2.6.)
2.2.6. Determination of cell concentration using the Coulter Counter 
(Model Dn)
The Coulter Counter works on the principle that cells suspended 
in isotonic saline will displace their own volume of electrolyte 
when passing through an electric field, and thus modulate the electric 
current passing between the electrodes. The resulting electrical 
impulse is amplified and applied to a digital counter. The electronic 
counting of cells is quicker and more reproducible than visual 
enumeration using a haemocytometer. In practice, 0.5 ml of the cell 
suspension is drawn through a 50 micron diameter orifice in an insulating 
wall between two electrodes. Threshold controls are set to exclude 
from count the small pulses due to cell fragments, platelets, etc. 
Automatic compensation is made for the error caused by the simultaneous 
passage of two or more cells through the orifice.
When counting a suspension of leukocytes, 0.1 - 1.5 % 10^ cells 
were diluted to 10 ml with ’Isoton' (a dust-free commercial isotonic 
electrolyte solution) and three drops of ‘Zaponin’ (an acetate-based 
lysing solution) were added to lyse contaminating erythrocytes. The 
optimum threshold was determined by calibration with peripheral blood 
lymphocytes, and was checked periodically.
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2.2.7» Statistical analysis
In any one group of observations, the standard deviation (s.d.) 
is given by ;
s.d. = / ^(x - x;^
n - 1 
where
X = A single observation 
n = The number of observations in a group 
X = The mean of n observations
The standard error of the mean (SEM) is given by :
s.d.SEM =
In population studies, there is a 93^ probability that any 
given value from a population will fall within 2 x s.d. of the mean 
value. In this thesis, the terra ’normal range’ refers to the 95% 
probability range.
Tests of significance
(a) Student's t-test;
When testing whether the mean values of two populations are sig­
nificantly different. Student's t-value is determined as:
in, - ra_
V 1^ 2^
where
ra^  and m^ = the mean values of each of the two populations 
and n^ = the number of components of the two populations
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2 2 
a ( n ^ - l ) + b  ( - 1 )
111 +  - 2
where (a) and (b) are the s.d. for and respectively.
The probability (p) that a difference between the two means 
occurs by chance will be a function of t and the number of degrees of 
freedom ( n^ + n^ - 2 ). The p-value is readily obtained from 
t-distribution tables, and where p •^ 0.03 the two means are considered 
to be significantly different. When testing whether the mean value, ra, 
of n observations is significantly different from a given value, v, 
the following expression is used to determine Student's t-value;
m -  V
(SEM)
(b) Student's paired t-test;
This analysis is applicable when dealing with two paired groups 
of observations. Thus;
where and x^ are paired observations, and d is 
the difference between them.
S(d) is the standard deviation of the mean difference 
for n pairs of observations, and is given by;
6(d) = I Z ( d  - d )2
n - 1
where d = Zd 
n
d
The value of Student's t-test is given by; t =
6(d)
55
2.3. INVESTIGATION OF THE ^'-NUCLEOTIDASE ASSAY CONDITIONS
2.3.1. results
2.3.1.1* The pH optimum of human lymphocyte 3'-^ucleotidase
Tonsil lymphocyte plasma membranes were used as a convenient 
source of 3'-N activity. Different buffers were used to obtain pH 
profiles over three different ranges. Apart from the buffer, the 
standard substrate mixture (see 2.2.3.) was used for the determination 
of 3'-N activity. ^ -glycerophosphate was retained in the mixture 
to inhibit any possible non-specific phosphatase activity (see 2.3.1.2.)» 
The pH of the reaction mixtures was determined at 37°C.
Barbital buffer (0.03 M) was used over the pH range 6.8 - 9.2 
(fig 4a), In this system, optimum activity was observed at around 
pH 7.2; both in the absence and presence of 10 mît MgCl^. In the 
absence of MgCl^ there was a sharp loss of 3*-N activity above pH 7*5; 
but in the presence of this salt, a second optimum appeared above 
pH 9.0. Similar results were obtained with Tris-HCl buffer over the 
pH range 3.3 - 8.6 (fig 4b), except that the activation observed with 
MgCl^ above pH 7*5 was less pronounced with this buffer. A dual buffer 
system employing 0.05 M sodium cacodylate and 0.03 M glycine was used 
to obtain a continuous profile over the pH range 5*9-10.6 (fig 4c).
This system buffered well between 5*9 - 7*7 and 8.1 - 10.6 when titrated 
with KCl and NaOK. In the absence of MgCl^, two pH optima were obtained : 
at about 7.1 and 9.0. In the presence of this salt, a broad plateau of 
optimum activity was observed between pH 8.4 - 9*8*
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The Tris-HCl buffer system was found to produce undesirably 
high background counts. Typically, the blanks gave counts of between 
8 - 1Cf/o of the standard. This compared unfavourably with the glycine 
and cacodylate buffers which gave blank counts of less than 1% of the 
standard, and with the barbital buffer which gave a blank count of 
1-2^  of the standard.
2.3.1.2. Inhibition of non-specific phosphatase activity
Intact human peripheral blood polymorphonuclear leukocytes 
were used as a source of alkaline phosphatase activity (Park, 1970).
The formation of adenosine from AMP was followed in the presence of 
0 - 100 jiM Ç -glycerophosphate using the basic 9'-^ assay described 
in 2.2.9» Contamination of the polymorphonuclear leukocyte preparations 
by mononuclear cells was determined by staining the cells with crystal 
violet and performing a differential cell count by light microscopy.
In the experiment illustrated here (fig 3) there was a 2,3^ contamin­
ation by mononuclear cells, and the contribution of the 9*-N activity 
of these cells to the breakdown of AMP by the polymorphonuclear cell 
preparation is indicated. About 89^ of the phosphatase activity 
of the polymorphonuclear cells was inhibited by 60 - 100 pm 
^ -glycerophosphate.
Sodium potassium tartrate, an inhibitor of acid phosphatase 
activity, appeared to interfere with the assay. Table 3 summarizes
the effect of tartrate on the activity of peripheral blood mono­
nuclear cells. The presence of 10 mM tartrate (the concentration
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Figure 5
THE INHIBITION OF. ALKALINE PHOSPHATASE BY ^-GLYCEROPHOSPHATE
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The shaded area represents the amount of 5 '-nucleotidase activity 
due to contaminating mononuclear cells in the polymorphonuclear 
leukocyte preparation.
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usually employed to inhibit acid phosphatase) increased the background 
counts of the assay by more than five-fold.
TàBLS 3
THE EFFECT OF SODIUM POTASSIUM TARTRATE ON THE APPARENT 
-NUCLEOTIDASE ACTIVITY OF PERIPHERAL BLOOD MONONUCLEAR CELLS
Buffer used 
5’-N assay
in
5’-N activity (nraol/hr/lO^ cells)
Concentration of tartrate (mM)
0 1 10
Tris-HCl, pH 5.2 0.0 0.0 5-8
Tris-HCl, pH 8.5 7.0 7.6 8.3
Glycine-NaOH, pH 8.5 11.0 11.4 13.0
2.3»1«3« Properties of the 3'-N assay
Intact viable tonsil lymphocytes (prepared as in 2.2.4.) were 
used to characterize the assay. Fig. 6 shows the results from
a typical experiment in which the percentage hydrolysis of substrate 
after 20 min reaction was determined for a range of cell concentrations. 
The rate of reaction was found to be linear up to about 3 %  hydrolysis. 
The rate of reaction was linear for at least 30 min provided that the 
substrate hydrolysis did not exceed 3 ^  (fig 7)*
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Figure 6
RELATIONSHIP BSTV7EEN TliE 5 ’-NUCIFOTIPASE ACTIVITY AND 
ENZYME CONCENTRATION
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Figure 7
RELATIONSHIP BETWEEN THE 5'^NUCLEOTIDASE ACTIVITY AND 
TIME OF REACTION
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In order to assess the extent of any apparent 'reverse 
activity that might result from the further metabolism of adenosine, 
the assay v/as performed with adenosine in place of the AMP substrate. 
(2-^H)-adenosine label was used at a concentration of 0.2 jiCi/ml to 
follow the reaction. The apparent reverse reaction at 2.0 j M
adenosine (which is the concentration of AMP used in the assay)
was 0.84 nrnol/h.r/10^ cells in a lymphocyte preparation that gave a 
5'-N activity of 24.0 nmol/hr/lO^ cells (fig 8). The underestimation 
of activity was therefore less than 3*5/^*
2.3.2. DISCUSSION
The effects of ions and glycine buffer on the pH profile
of human lymphocyte plasma membrane were similar to those observed
with bull semen plasma 3'-^ (Bodansky & Schwartz, 19^3; Levin & Bodansky, 
1966). The properties of the human lymphocyte enzyme therefore resemble 
those of the liver plasma membrane enzyme from various species rather 
than the pig lymphocyte plasma membrane enzyme (see 1.1.4.).
The differences between human and pig lymphocyte membrane 3'-% 
emphasize the need for checking the suitability of the assay conditions. 
The results obtained here with Tris-HCl buffer (fig 4b) show that the 
original conditions employed by Avruch & Wallach (l97l) (Tris-HCl 
buffer, pH 8.3* with Hg*^ ’*') are sub-optimal for human lymphocyte 3’-N. 
Furthermore, the background counts obtained with this buffer are higher 
than those obtained with the other buffers studied. The use of Tris-HCl 
buffer therefore results in an unnecessary loss of sensitivity.
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For the routine measurement of 5’-N activity, Glycine-NaOH buffer, 
pH 8,5i was used with 10 ftiM MgCl^. At this pH, the inclusion of an 
inhibitor oi acid phosphatase activity was considered unnecessary. 
However, ^-glycerophosphate was included as a precaution against 
possible alkaline phosphatase activity; although in practice, human 
circulating mononuclear cells were found to have a negligible non­
specific phosphatase activity under these assay conditions compared 
to their activity. The substrate concentration employed (20^M)
is about double the value of the apparent Michaelis constant 
(see 3.3,2.). Although the modified assay showed a linear release 
of adenosine up to about 35/^ hydrolysis, this is considerably less 
than the 80^ reported for the original assay with rat fat cell 
membranes (Avruch & Wallach, 1971). However, the working range of 
the assay was more than adequate.
Chatterjee, Ehattacharya & Barlow (1979) have recently criticised 
this type of assay in which ZnSQ^ and BaCOH)^ are used to quantitatively 
precipitate AMP. They suggest that because adenine, guanine, guanosine, 
hypoxanthine and inosine are also precipitated under these conditions, 
the presence of ADA (adenosine deaminase) would lead to an under­
estimation of the activity. However, the results shown in fig 8
suggest that this criticism is not valid for the assay of lymphocyte 
employed in this study. Presumably the activities of ADA and 
adenosine kinase are small compared to the activity under these
assay conditions.
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2.4. THE 3’-NUCLEOTIDASE ACTIVITY OF CIRCULATING MüNüNUCUL-lR CELLS 
FROM NORMAL INDIVIDUALS AND PATIENTS
2.4.1. PATIENTS STUDIED
2.4.1.1. Patients with X-linked hypogammaglobulinaemia
Ten patients, aged 9 - 28 yrs, were studied. All had affected 
male relatives and were receiving weekly gammaglobulin injections.
The percentage of B-lymphocytes in the circulating mononuclear cells 
of these patients was less than 1% when tested either by fluorescent 
antibody or by resetting techniques (see chapter 3)* The mean serum 
IgG concentration was 2,8g/l (range, 0.5 - 4.6) and the IgA and IgM 
levels were less than O.lg/l.
The normal ’95f^  range' found for serum immunoglobulin concentrations 
in the immune-deficiency referral laboratory at the Clinical Research 
Centre is as follows: IgG, 5-9 - 17*2g/l; IgA, 0.5 - 4.0g/l:
IgM, 0.6 - 2.0g/l.
2.4.1.2. Patients with 'common variable' hypogammaglobulinaemia
Twenty six patients with CV-H, aged 7 -51 yrs, were studied.
All but four developed their disease after the age of sixteen. The 
mean serum IgG concentration in these patients was 2,5 g/l (range 
0.7 - 6,4); one patient, P.M., whose IgG level of 6.4 was just within 
the normal range, had undetectable levels of IgA and IgM by the radial 
immunodiffusion technique. All the patients had less than 0*1 g/l 
serum IgA, and 60^ had less than 0.1 g/l serum IgM; the range of serum
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IgM concentrations for all the CV-H patients being from less than 
0.1 g/l to 0.6 g/l. These patients were receiving regular gamma­
globulin replacement therapy.
2.4,1.p. Patients with selective IgA-deficiency (IgA patients)
Six patients, aged 7 ~ 33 yrs, were studied. All had less 
than 0.1 g/l serum IgA and normal levels of IgM and IgG. All the 
patients suffered recurrent chest infections. Patient N.G. had 
Wegener's granuloma, and his sister had died with severe hypogamma- 
globulinaemia and neutropenia,
2.4.1.4. Patients with Chronic Lymphatic Leukemia
Thirteen patients with CLL were studied in this thesis. Their 
mean age was 62 yrs (range 48 - 7^) and the number of patients in 
each of the clinical stages of the disease as defined by Rai et al 
(1973) were: Stage 0, 2 patients; Stage I, 1; Stage II, 5; Stage III, 4; 
Stage IV, 1, Patient T.R., was unusual in that he had a grossly enlarged 
liver (with an apparently normal histology on biopsy) without any 
enlargement of the spleen or lymph nodes. Also, the morphology of the 
leukemic cells from this patient, together with the density of surface 
immunoglobulin, were suggestive of a more differentiated cell than is 
characteristic of CLL, This patient showed some characteristics of 
both CLL and prolymphocytic leukemia (Catovsky, Costello, O'Brien &
Cherchi, 1979), Four patients were receiving treatment at the time of 
study: two were receiving chlorambucil, one was receiving allopurinol with
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chloraniDucil, and the fourth v/as receiving cyclophosphamide, 
vincristine, and prednisolone,
2 .4.2. RESULTS
2.4.2.1. The 3'-nucleotidase activity of circulating mononuclear 
cells from patients with CLL or hypogcu-nmaglobulinaemia
The 3'-N activities of circulating mononuclear cells from 26 
CY-il patients, 10 X-H patients, and 4o healthy subjects, are compared 
in fig 9. The ages of the patients ranged from 7 - 3 1  yrs, and the 
controls ranged from 19 - 32 yrs. Ten of the 26 CV-H patients had a 
3*-N activity that was below the normal range. The X-ÏÏ patients 
showed a similar distribution of 3'-N activities to the CV-H patients, 
although only one was below the normal range. Only six patients with 
IgA-deiiciency were available for study, and the results were in­
conclusive. The mean activities of the CV-H and X-H patients were 
both significantly lower than normal (Student's t-test, p ^  0.001), 
but the mean activity of the IgA-deficient patients was not significantly 
different from either the mean normal activity or the mean activity 
of CV-H patients.
The 3'-N activities of 10 patients with CLL were compared with 
those of 20 normals of ages 4o - 82 yrs (fig 10). Eight patients, were 
below the normal range, and one (patient T.R.) had an activity that 
was about twelve times higher than the normal mean, . The mean 5'-N 
activity of the 20 normal donors above the age of'y40 was significantly 
less (Student's t-test, p O.OOl) than the mean activity of the 4o 
donors between the age 01/19 - 3-* / 1
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Figure 9
5 '-NUCLEOTIDASE OF CIRCULATING MONONUCLEAR CELLS FRŒ4 PATIENTS 
V/ITH HYPOGAMMAGLOBULINAEMIA
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Figure 10
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The ages of the controls ranged from 40-82 yrs, and the vertical bar 
represents the 'normal range' of 5'-nucleotidase activity.
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2.4.2.2y The 3*-nucleotidase activity of the circulating mono­
nuclear cells from the parents, of some patients with 
hypogammaglohulinaemia
The 3*-N activities of circulating mononuclear cells from 
eleven parents (3 fathers and 8 mothers) of patients with CV-H, and 
from six mothers of patients with X-H, are compared in fig 11. The 
patients in question all had a 5'-N activity that was below the normal 
mean. Because of the decrease in the 5'-N activity in older subjects, 
the results are expressed in the form of a scatter-plot. The parents 
appeared to have a normal activity for their age.
2.4.3. DISCUSSION
Using the modified assay described earlier, reports in the 
literature of low 5’-^ activity in the majority of patients with CLL 
have been confirmed. Patient T.R., who had a supranormal level of 
5 ’-N activity presented with unusual clinical and morphological 
features (see 2.4.1.4.), but other CLL patients with supranormal 5*~N 
activity have been reported previously (Quagliata et al, 19?4;
LaMantia et al, 1977; Kanter et al, 1979)» The original observation 
of low 5 ’~N activity in many patients with CV-H (Johnson et al, 1977) 
has also been confirmed. The apparently normal 5'-N activities reported 
in the six patients studied by Edwards et al (1978) may be due to the 
limited number of patients studied. In addition, most of their patients 
had an onset of symptoms in the pediatric age-group (personal communication, 
Irving H. Fox) and were therefore clearly different from the 'adult onset'
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Figure 11
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patients studied by Johnson et al (1977); although Webster et al,
(1978) showed that 'childhood onset' and 'adult onset' CŸ-H 
patients had similar 3'-N activities. The limited number of patients 
studied also appears to be the cause of the conflicting results 
obtained with IgA-deficient patients. If the results obtained by 
Webster et al (1978) and Edwards et al (1978) are considered together 
with the results obtained here, it appears likely that these patients 
may show a similar distribution of 5'-N activities to the patients 
with CV-H. The results obtained with X-H patients in this thesis 
(see also 3*3.1.) suggest that both the very low 5 *~N activities 
reported by Edwards et al (1978) and the low-normal values reported by 
Webster et al (1978) are found in these patients, and that the scatter 
of 5’-N levels is greater than was previously thought.
In view of the lack of convincing evidence for a hereditary 
defect in the majority of CV-H patients, it v/as perhaps not surprising 
that the parents of these patients had a normal activity (fig 11),
The heterozygote mothers of X-H patients also had normal levels of 
5'-N activity. Thus, in this limited investigation, no evidence v/as 
found to suggest that the low levels of 5‘~N were inherited.
73
CHAFFER 3
THB NATURE OF THE 5* -NUCLEOTIDASE DEFICIENCY IN HYPOGAMMAGLOBUDINAEMIA
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3.1. INTRODUCTION
The apparently Isolated biochemical ahnoiTnaUity of, low 5*~N activity 
in some Z~H and CV~H patients (Webster et al, 1978) provides us with a 
potential tool for clarifying the function of the enzyme. Elucidation of 
the cause and consequences of the low enzyme levels in these patients should 
hopefully provide vital clues as to the function of the enzyme In lymphocytes.
There are a number of possible explanations for the reduced 5*“N 
activity in the patients. At the biochemical level, the enzyme molecule may 
be defective or under the control of a regulatory factor. Alternatively, 
the rate of synthesis or degradation of the enzyme may be altered; resulting 
in fewer enzyme molecules per cell. At the cellular level, there is the 
possibility that a population of cells particularly rich in activity
may be absent. Since patients with Z-H lack circul.ating B-cells, and when 
these cells are present in CV-H patients they are functionally defective, 
these cells appear to be likely candidates for the cause of the low 5*“N 
levels at the cellular level. However, B-cells represent only a minor per­
centage {h"26%) of peripheral blood mononuclear cells (Gmelig-Heyling & 
Ballieux, 197?) and previous workers have been unable to detect a difference 
between the 5*~N activity of B- and T- cells from normal individuals (see 
1.1.8.).
The experiments in this section were designed to investigate the 
cause of the reduced levels of 5*-N in CV-H and Z-H patients. In addition 
to kinetic studies, the situation regarding the level of on B- and T-
cells was reinvestigated using recently developed improved procedures for 
isolating these cells. The results obtained with the mononuclear cells of 
patients were compared with those of cord blood mononuclear cells which also 
have less activity than the cells from healthy adults (see 1 .1.8.).
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3 . 2 .  MATERIALS & HBI’iI0D,3
In order to avoid unnecessary repetition, only the, materials and 
methods not already described in chapter 2 are given here. Sterile 
precautions were taken where appropriate.
3.2.1. Materials
Chemicals and other materials were obtained from the sources listed :
Antibody solutions see 3.2.3*
Cells: Ox erythrocytes WATFORD SLAUGHTER HOUSE
Sheep erythrocybes TISSUE CULTURE SERVICES
Chromic chloride BDH
Foetal calf serum GIBCO BIOCULT
L‘-Glut amine BDH
Heparin PAINES & BYRNE LTD
Neuraminidase BEHRINGWER&E AG, MARBURG
Penicillin GLAXO
R.P.M.I, l6i|0 medium, buffered with either bicarbonate or hepes
PLOW LABORATORIES, 
SCOTLAND
Sodium aside BDH
Sodium metrizoate NYEGAARD & CO., OSLO
Streptomycin GLAXO
Triton X-100 BDH
Bijou culture bottles (plastic) STERILIN LTD
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3.2.2. Patients studied
Fourteen patients with CV-H were studied (ages 19-51 yrs), eight 
of whom were included in previous study. Eight patients with X-H were 
studied (ages 9-28 yrs), three of whom were included in the previous study. 
The serum immunoglobulin levels and the treatment of these patients were 
similar to those described in chapter 2. The mean age of the normal adults 
used as controls was 31 yrs (range 21-68 yrs). Cord blood was obtained 
from placentae following normal full-term deliveries.
3.2.3. Goat antibodies to human immunoglobulins
Antibody solutions were kindly provided by Dr. T.A.E. Platts- 
Mills (Depr. Immunological Medicine, C.R.C.). The preparation of such 
large quantities of specific antibodies from commercially-available anti- 
sera would have been unnecessarily expensive. Goat antisera to human 
immunoglobulin were raised, and the antibodies purified as described by 
deGast & Platts-Mills (1979). Briefly, anti-IgM antiserum was passed 
through a human IgG immunoabsorbent column to remove antibodies to IgG 
and light chains. The anti-IgM antibodies were then purified by specific 
adsorption to a human IgM column. This antibody solution did not show any 
anti-IgA, anti-IgG, or anti-light chain activity. An anti-IgG antiserum 
was purified by specific adsorption to a human IgG column. This anti­
body solution showed a strong anti-IgG and anti-kappa light chain activity. 
The anti-IgM and ’anti-IgG' antibody solutions were mixed 1:1 to give an 
anti-Ig antibody solution that was used for the isolation of surface-Ig 
positive (slg^) cells.
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3'2.L. Isolation of peripheral blood mononuclear cell populations
Since relatively large nmabers of cells were required for these 
experiments, heparinized blood was used in preference to deflbrinated 
blood. Heparinized blood generally yielded about twice as many mononuclear 
cells as deflbrinated blood, and the presence of platelets did not interfere 
with the isolation procedures or the 5’-N assay. Before separating the 
mononuclear cells on a Ficoll-Triosil gradient (2.2.2.), the blood sample 
was diluted with an equal volume of R.P.M.I. (hepes) medium: otherwise the 
cell separation tended to be poor due to * overloading» of the gradient. Sub- 
populations of the mononuclear cells were isolated according to the scheme 
outlined in fig, 12,
3.2.I4.I. Separation of rosetting and non-rosetting lymphocytes by 
density-gradient centrifugation on Ficoll-Metrizoate 
(specific gravity, 1 .090)
The use of Ficoll-Metrizoate to separate rosetted cells was 
described by Pariah & Hayvfard (1971-î-b). The separation medium was pre­
pared from 12 parts of llf? Ficoll UOO (wt/vol) and $ parts of 32^ sodium 
metrizoate. The rosetted cell suspension was layered onto this Ficoll- 
Metrlzoate mizcture, and centrifuged at room temperature for 30 min at 1200g* 
The best separations were obtained by attaining the 1200g force within 20s 
by rapid initial acceleration. Red cells and rosetted cells were recovered 
from the pellet, and the non-rosetted cells were recovered from the gradient 
interface. The pellet was washed once in PBS before subjecting to ammonium 
chloride lysis (see 2.2.3*) to remove the erythrocytes.
3.2.U.2. Separation of T-cells by E-rosetting
The procedure for isolating T-cells was essentially that of Gmelig- 
Meyling & Ballieux (1977), which utilises the property of these cells to
78
Ficure 12
5CF FOR THE ISOLATION OF MONONUCLEAR CELL SUBPOPULATIONS
PERIPHERAL BLOOD 
MONONUCLEAR CELLS
Rosetted ceils 
(T-ceHs )
Rosetted cells 
{discarded )
E-rosettes
Non-rosetted cells
En-rosettes
I
Non-rosetted cells 
( 'non-T‘ cells )
Rosetted.cells 
(slg+ceHs )
Ox-E-anti-lg 
'"l rosettes in the 
V presence of azide
Non-rosetted cells 
(E-slg-ce!Isl
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form spontaneous rosettes with sheep erythrocytes (E-rosettes). Sheep 
erythrocytes, which were less than one week old and stored in Alsever*s 
solution, were washed three times in PBS immediately before use. Foetal 
calf serum (FCS) which had been inactivated by heating to for 30 min,
was absorbed for 2 hr at U°C with one fifth volume of packed sheep cells.
g
Up to 10 human cells in L ml of R.P.M.I. (hepes) medium were added to 3ml 
of absorbed FCS and ml of 10^ (vol/vol) sheep erythrocytes. The E- 
rosettes were separated by centrifugation on 10 ml of Ficoll-Metrizoate as
described in 3.2.L.I.
The non-rosetted cells were subjected to a second cycle of resetting 
with neurnmnniiase-treated sheep erythrocytes to remove any remaining T-cells; 
thus giving a » clean» non-T cell preparation. The rosetted cells from this 
step (Sn-rosettes) were discarded. Neuraminidase treatment is believed to 
enhance the stability of the E-rosettes without affecting the specificity 
(Webster & Asherson, 197W* A 2.5^ suspension of sheep erythrocytes in PBS 
was incubated with 90 u/ml neuraminidase at 37^0 for 20 min. These cells 
were washed three times and used for En-rosette formation on the same day.
3.2.h.3* Separation of sig* cells by resetting with Ox erythrocytes coated 
with anti-Ig
The procedure for isolating human sig* cells was that described by 
da Gast & Platts-Mills (1979) which was developed from an earlier method for 
the isolation of rat sig* lymphocytes (parish & Hayward, 197Lb). Goat anti­
human antibo'dies (see 3.2.3.) were coated onto Ox erythrocytes using chromic 
chloride. A stock solution of 1.% CrCl^ in 0.85^ NaCl was prepared, and the 
pH adjusted twice weekly to pH 5.0 with NaOH for three weeks. The use of 
»aged» CrClj gave more consistent results. The concentration of CrCl^ 
required for coating the antibody to the Ox cells was predetermined for each
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batch of cells. Freshly collected Ox red cells in Alsever»s solution 
were washed five times in unbuffered 0.85% saline immediately before use.
-One hundred microlitres of diluted normal goat serum (adjusted to O.lmg 
protein/ml) and 50jil of packed erythrocytes were added to 0.8ml of saline. 
Two-fold dilutions of CrCl^ were made in 0.02 M sodium acetate buffer, pH
5.5, and 1.0ml volumes were added dropwise to the cell suspensions using 
a vortex miser. After 10 min at 20°C, the reaction was stopped by the 
addition of 2.0ml of PBS. The coiç)led cells were washed twice and re- 
suspended in 2-3ml of PBS. The concentration of CrCl^ immediately below 
that which caused microscopic agglutination was used as a guide to the 
concentration required when coating with the antibody solution (usually 
between 0.001 and 0.005%) • Three concentrations around the predetermined 
concentration were then tested for coating the antibody solution (adjusted 
to O.lmg protein/ml) to the Ox cells; and the highest concentration that 
did not cause micro-agglutination of the cells was used to prepare a larger 
batch of cells. Provided fresh Ox calls were used, and sterile precautions 
talc en, the coated cells could be stored for up to 2 weeks in P3S at 
Cell lysis or agglutination did not usually occur during this period of 
storage and the resetting capacity of these cells was unimpaired.
*Non-T* cells were washed and resuspended in R.P.M.I. (hepes) with 
10% FCS at a concentration of up to 20 x 10^ cells/ml. An equal volume 
of 10% coated-Ox cells (vol/vol) was added to the cell suspension in an 
ice bath at 0°C. This mixture was spun at 200g for 7 min at h^C. After 
making 0.1% with respect to sodium azide, the pellet was gently resuspended 
and allowed to warm to room temperature before separating the rosetted 
cells on a Ficoll-Metrizoate gradient containing 0.1% azide. Capping of the 
surface immunoglobulin was inhibited at I;°C; but once formed, the rosettes 
were stable at room temperature (Parish fit Hayward, 197ba). The low temperature
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and the presence of azide also inhibited, the forraation of Fc-rosettes 
(Parish & Hayv;ard, IppLa), The slg^ cell preparations contained less 
than 2% E-rosetting cells, but contained up to 20% monocytes as demon­
strated by cytocheraical staining for cZ-naphthyl esterase (deGast et al,
1979).
3.2 Ju.U. Determination of the 5’-nucleotidase activity of the 
mononuclear cell subpopulations.
Unless stated otherwise, all the cell preparations were cultured 
overnight before assaying for 5»-N activity. The cells were suspended in 
lôlj.0 medium buffered with bicarbonate and supplemented with 2mM 
glutamine, 100 iu/ml penicillin, 100 j-ig/ml streptomycin, and 10% heat- 
inactivated FCS (R.P.M.I. (bicarbonate)-FCS ). After I6-I8 hr incubation 
in plastic bijou bottles at 37°C in humidified air with $% CO2, the cells 
were washed three times in TBS and assayed for in the usual manner.
3.2.5. Determination of the apparent Hichaelis constant for 
5»-Nucleotidase
The initial rate of reaction (Vi) for on intact circulating
mononuclear cells was determined for six concentrations of AMP ranging 
from 5-50 The reaction m:ixture was the same as that for the routine
5*-N assay except that the concentration of ^glycerophosphate was raised 
to l50jxM to ensure efficient inhibition of alkaline phosphatase activity 
at the higher substrate concentrations. The apparent Michaelis constant 
(Km) was calculated from plots of Vi against Vi/S, where S is the substrate 
concentration (Sadie, 19^2). The Michaelis-Menten equation may be written 
in the fonn:
Vi , = Vmax ~ Km. Vi
S
where Vmax = the maximum velocity of reaction. The Km is therefore given
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as the slope of the plot of Vi against Vi/S, A computer program was used 
to determine the Km by the method of least squares, together with the 
standard error. The S M  was normally less than 10%.
3 .2.6 . Mixed cell cultures
Allogeniec cell-mixture experiments were performed by culturing equal 
numbers of circulating mononuclear cells from two individuals together in 
the R.P.M.I. (bicarbonate)-FCS cultui'e medium described in 3^2,h»h» Cultures 
were set up in plastic bijou bottles with 2 x 10^ cells in 1 .5ml of medium. 
After incubating for I8 hr3 at 37^C, the cells were washed three times in 
T3S and assayed for 5’*~N.
3.2.7. Solubilization of cells with Triton I-lOO detergent
Circulating mononuclear cells were washed and resuspended in TBS to 
give 10 - 10 cells in a volume of 0.1:5ml. The cells were lysed by the
addition of 0.05ml of 10% (vrt/vol) Triton X-100 detergent. The 5*“N acti- 
■vity was then determined in the usual manner in a final volume of 1.0ml.
3.2 .8. Disruption of cells by freeze-thawing
Circulating mononuclear cells were washed and resuspended in TBS at 
a concentration of 2 x 10^ cells/ml. Aliquots of 0.2ml were removed for 
5»-N determination, and the remainder frozen to -20°C and stored overnight 
before thawing. Less than 5% of the cells remained intact after this treat­
ment. ’Particulate» and ’soluble’ fractions were obtained by centrifugation 
at 20 OOOg for 1:5 min at L°C. The particulate fraction was then washed 
once in 10 mM tris-buffered HgO, pH
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3.3. RESULTS
3-3*1* A reassessment of the 5^-N activity of clrciLl-ating mononuclear 
cells
Since the experiments in this section involved the measurement of 
the 5’~N activity of cells obtained from heparinized blood (rather than 
deflbrinated blood), and because the cells were cultured overnight before 
assaying, the data on circulating mononuclear cell 5»-N have been re­
presented in fig 13* The 5*-N activities shown here are appreciably higher 
than those obtained prexdously (see 2.n*2.1. , fig 9)* However, comparison 
of the CV-H and X-H patients with the normal controls revealed the same 
pattern of results as obtained pre^/iously. Of the patients studied here, 
seven out of li; CV-H patients and five out of eight X-H patients had a 
activity below the normal range. In addition, the mononuclear cells from 
eight out of eleven cord blood samples had a activity that was below
the normal adult range *
3.3.2. The apparent Michaelis constant of 5»-nucleotidase with AMP 
as substrate
A typical Eadie plot, from which the apparent Km was determined, is
shown in fig 3J;. The mean (_+ s.d.) Km obtained idLth 12 healthy adults was
9.6 2 2.7 pH AHP. As shown in fig 15, the Km values obtained, with foisr
X-H patients and six CV-H patients were all id.thin the normal adult range;
and the mean values were not signi.ficftntly different from normal (Student’s
t-test, pj>0,25). Of the eight cord blood samples investigated, seven were
within the normal range; the remaining sample gave a Km of 31.8 pH AHP
/
(SEM = + 3.9). The patient and cord blood samples investigated had a 5 ’-N 
activity that was at least one standard deviation below the normal mean.
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Figure 14
AN eadie PLOT FOR THE DETERMINATION OF THE Km OF 5 '-NUCLEOTIDASE
25
20 -
to
*CD
O
CO
CD
O
E
c
15
10
0
Slope = Km 
= 10.1 ijM
X
0 0.5
T "
1.0 1.5 2.0
Vi/S ( ml/hr/10'" cells)
Figure 15
THE APPARENT Km OF 5 ' -NUCLEOTIDASE ON CIRCULATXNG MONONUCLEAR CELLS
D_
<
E
c
CD
ro
CL
CL
<
30
12 —
8
0J
%»
»
Normal X-H CV-H Cord 
blood
87
The CLL patient, T.R., who had a supranoiraal level of 
activity (fig 10, 2 J4..2,1.) was foimd to have a noiTOal Km of 11.6 jM 
M P  (SEM = + 1.5).
3.3.3. Mixed-cell cuJ-tiires ; the effect on 5  ^-M activity
Table U summarizes the results of the experiments performed to 
investigate the possibility that circulating mononuclear cells may produce 
a soluble factor that regulates the 5*-M activity. When cells from CV-H 
patients or from cord blood were co-cultured for 18 hrs with cells from a 
healthy adult, the 5*-N activity of the cell mixture was always found to be 
close to the mean actiirity of the two cell populations when cultured alone. 
Similarly, co-cultures of cells from two heal.thy donors revealed that short­
term cultures of allogeneic cell mixtures did not affect the 5-M activity.
The cellular location of 5^-Nucleotidase
Since the routine measurement of 5*“W activity is performed on 
intact cells, it is conceivable that low levels of 5*~N activity may be 
the result of some of the enzyma being located intracellularly. Disruption 
of circulating mononuclear cells with Triton X-100 detergent caused an 
increase in the 5'-M activity (table 5). However, neither cells from 
patients nor cells from cord blood showed a significant increase beyond 
that observed with cells from healthy adults. Circulating mononuclear cells 
from CV-H patients and healthy adults did not show an increase in 5 ’~N 
activity when disrupted by freeza-thaw (table 6). The 5*~H was located in 
the * particulate* fraction of the cells from both CV-H patients and normal 
subj ects.
3.3.5. The 5* -nucleotidase activity of normal mononuclear cell 
subpopulat ions
Mononuclear cells obtained from 20ml samples of normal adult blood 
were depleted of T-cells by two cycles of resetting (3.2.b^2.). The 5*"N
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table U.
5*-!EJCLE0TIDASE ACTIVITIES (nmol AMP/hr/10 cells) OF CIRCULATING 
MOEOMUCLEAR CELL MIXTURES MA.IMTAnîED CULTURE FOR l8 HRS.
Control A alone 
Control B alone 
Control A + Control B 
Patient alone 
Patient + Control A 
Patient + Control B
Experiment 1
15.6
10.6
13.9 (13.1) 
z.h
9.3 (9.0)
6.3 (6.5)
Experiment 2
16.1
19.1
17.6 (17.6)
.3
10.1 (9.2)
11.2 (10.7)
Control C alone 
Cord blood alone 
Control + cord blood
Experiment 3
IU.7
U.7
7.9 (9.7)
Experiment h
13.6
3.8
8.1 (8.7)
Each experiment was conducted with different controls and patients. 
The figures in parentheses denote the expected mean activities
of the cell mixtures.
89
TABLE 5.
THE EFIEGT OF TRITON X-100 DETERGENT ON THE 5^  -NUCLEOTIDASE
ACTIVITY OF CIRCULATDÎG MONONUCLEAR CELLS
Source of cells Activity of solubilized cells _ ^
Activity of intact cells % I W  + o.d,
Normal 136 2  8 (n=9)
Cord Blood llfL 2  9 (n=5)
CV-H ll|7 1 20(n=6)
X-H ].L8 + 23(n=W ^
Not significant (p^O.l using Student's t-test).
TABLE 6,
5/-NUCLEOTIDASE ACTIVITY (nmol AMP/hr/lQ^ cells) OF CELLS
DISRUPTED BY FREEZE-THAVmiC
90
Subjects Intact cells Freeze-thawed cells
Homogenate particulate"^' soluble 
fraction fraction
NORMAL 17.9 
13.3
12.9
17.5 
12.3
11.5
16.6
12.5
10.7
0 .U 
0.3 
0.3
CV-H patients 17*9
1.7
18.5
7.U
1.1
17.7
6.7
0.6
O.U
0.1
0.0
The "particulate" fraction was obtained by centrifugation at 20 OOOg 
for mins. and washing with lOrM tris-buffered H^O, pH 7.5*
91
activity of the 'non-T' cells was not significantly different from the 
total mononuclear cell preparation (table 7)* However, this type of 
experiment suffers from the drawback that the *non-T' population con­
sists of two major cell populations (B-cells and monocytes) that may have 
different activities. Similar experiments were therefore performed
with tonsil cell preparations which are nearly pure lymphocytes. Since 
tonsil lymphocytes initially show a significant, but inconsistent, decrease 
in 5'-H activity during culture (see li.3.3*)5 it was decided to use tonsil 
Ijnaphocytes that had been cultured for 2-i; days; by which time the 5* -H 
activity was relatively constant. These cells were separated into T- and 
'non-T' populations by a single cycle of En-rosetting and assayed immediately 
for 5' -N acti^ vi-ty. As shown in table 8, the T-cells had significantly leas 
5'~N acti*‘riLty than the unseparated cells, while the 'non-T* cells had sig­
nificantly more 5'-H activity.
When both T- and B- cells were isolated from blood by positive 
selection (see fig 12; 3«2.It.), siuailar results to those with tonsil lym­
phocytes were obtained (table 9) • The cells with neither B- nor T- cell 
markers (E"slg~ cells; presumably monocytes and 'null* cells) had a very low 
activity, although this was found to increase during culture (table 10).
3.3.6. The 5*“Nucleotidase activity of mononuclear cell subponulations 
from cord blood and from patients with CV-H and X-H.
Because of the low numbers of B-cells present in many patients with 
CV-H, 100ml of blood was usually collected for the isolation of mononuclear 
cell subpopulations. Fifty millilitres was usually adequate for normal 
adults. With cord blood samples, sufficient numbers of cells were usually 
obtained from 25-30ml samples.
TABLE 7.
THE 5'-NUCLEOTIDASE ACTIVITY OF 'NOH-T' CIRCULATDTG
MONONUCLEAR CELLS
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Experiment 5*-N activity (nmol AMP/hr/10 cells)
Total circulating 
mononuclear cells
*IJor-T' cells
1 13.9 15.2
2 H 4..3 13.0
3 18.0 21.14
k 18.7 15.9
5 25.7 25.7
6 26.5 31.5
7 27.7 32.5
8 28.0 25.8
mean s.d. 21,6 + 6.0 22.6 + 7.5*
Not significantly different (Student's paired t-test, p ^ 0.25)
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TABLE 8.
THE 5*-NUCLEOTIDASE ACTWITY OF TONSIL LYî^PHOCTTE POPULATIONS
Experiment 5*-N activity (nmol AjMP/hr/10^ cells)
Unseparated cells En cells En~ cells
(T-cells) (B-cells)
1 7.2 U.3 29.7
2 10.8 7.1 22.9
3 13.1 5.9 2i5.8
U 13.7 9.h hh.9
5 ll+.li 3.7 22.it
6 lU.9 11.1 25.5
7 15.9 6.3 30.8
8 19.7 6.3 51i.O
mean + s.d. 13.7 + 3.7 6.8 + 2.5* 3it*5 + 12.0*
* Values significantly different from the 5'-S activity of unseparated
cells, (student’s paired t-test, p <C0.00l).
94
ta
°
EH
I
I
CO
I
I
I
g
I
eo
P’H
o
to
r4
Ü
\oo
o\
PQ
f;
I
y
gM
E-itLD
8
g
I
I
ÎÂ
I
o
A
CO -p •H
1—1 P»
r—t h Ü<D 0) tiJ
Ü CVi
CO
1 + ! II CtJ iW
H m t j tA
to
1 ■ S -P
H
1
ft
CD
to
1
I
ow
H
•P
*s ViH  to o C5
(D H H Pi Ü P i
O H On Q> •H+ oi +  ! I!
W  Ü •H -p
H  ; ON to P3 to
10 A • H op 0>
1 ^ - r t H H •p
M ‘UN <D to t
O
(d
-p
1 M
w
H c) 3
to
I
A §
M to xJ
1 -PH CO
to ■P
ÎH €d§ y §
o P i H
T l a -P'' ^ td
to to • A Pi
A H
0 0 c33 to A0) Ü +  1 P
Ü  O . It Pi <D P.
f P O P i
+ EH ' «H h3
TiJ
to 3
5
o
p-
+ 1 RQ)s to* ' i
O iH P
6 y §
o o P
to i-P +
w
<D Û) H
U Pi to
tg
fi O n O
3 g -P
o> "lA 3
H î> P
Ü + { O •H +CM t ù A -P
a On n
o 0 05 «H
G On 0) O O
O 1—1 a
0.
y *8
T j
> >
o g
+■> o R
o A P o
E4 EH P -p
95
S
ii
fH
TO
VO
S
Ü
p.
g
1
■UN
I
S
I*
CM
I
VO vO
vD
i— i
t>-
H
lA
k
CO
(À
O
<À
0\
m
c?
o
CO
CM
VO
O
CM <A
t
10
.ë
■LA CM
.§
Pt-
XJ
■P
§
to
P OO
0 1—1
ft
•H p
ft p
«H
■ ei
cd
•0
gTO
o
xî
p o
ft s
o td
(«H Xj
0 TO
X) r-i
y
o O
o O
h P
■ë «H
§
O
0
'ri «S
O P
TO O
W TO
P P
g
k
h> P
I—1 P
O 4-1
0 (d
•H
P
0 r-l
O P
P P
O
M •'d
G> P
> g
TO
d P
p P
o
fH O
w «H
p f-t
H P
O P«
ë TO
O Ctf
0 >
S b
(D
cjTO
TO
EH P
❖
!
-püp
&
p
ft
OJ
oS
H
I
96
4 *4“ 'f’
Isolation of E and sig cells from CV-H patients revealed that 
the subnormal levels of 5‘-N activity were not confined to a single Ijen- 
phocyto subpopulation (table 11). Eight out of 13 CV-H patients showed 
a subnormal level of T-cell 5*~N activity, and four out of seven had a 
subnormal B-cell 5*-N activity. . Four CV-H patients had insufficient 
numbers of B-cells for practical isolation. There was no consistent 
pattern of B- and T- cell acti^vity in the patients studied : three
patients (A.W., S.C., & R.C.) had a low level of activity on both B-
and T- cells, while patient C.M. had a normal T-cell value and a low B-cell 
value, and patient G.R. had a low T-cell value and a normal B-cell value*
The mean (+^ s.d.) activity of the E*"slg cells from 12 CV-H patients
was 5.6 2 5.9 nmol AMP/hr/10*^ cells, wiiich was not significantly different 
from the acti'^ /ity of these cells from normal blood (see table 9). Of the 
eight X-H patients studied, four had a low level of T-cell activity. No 
pattern of 5*-N activity was observed in the two families of X-H patients.
Cord blood B-cells consistently had less 5'‘'-N activity on their 
B-cells than was present on the B-cells from healthy adults. However, only 
four out of seven samples had less 5’”H activity on the T-cells than adult 
T-cells; although they were all below the normal adult T-cell mean activity.
3.1. DISCUSSION
The apparent Km of around 10 jiH AMP obtained here for human lympho­
cyte ecto-5*“N is in reasonable agreement with the values of U-63 re­
ported for purified 5'-N from various sources other than the cytoplasm of 
liver cells ( Song & Eodansky, 1966; Widnell & unkeless, 1963; Burger & 
Lowenstein, 1970; Sullivan & Alpers, 1971; Evans & Gurd, 1973; Nakamura 
1976; Domand, Eonnafous & Mani, 1978). There have been, few reports of 
Km determinations on the enzyme from human sources. Song & Bodansky (1966)
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Footnote to Table 11 :
Where too few (less than 2%) sig* cells were present for isolation, this 
is indicated by (-), and n«d. denotes not determined»
The CV-H patients, S.C., R.C., J.F. and C.M., were childhood-onset; the 
other nine CV-H patients were adnlt-onset.
^Denotes values witliin the normal adult range (mean _+ 2 s.d.)»
(a),(b). These X-H patients were brothers»
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TABLE 11.
THE 5'-N ACTBLTTY (nmol AMP/hr/10^ cells) OF CIRCULATDTG MONONUCLEAR 
CELL SUBPOPULATIOHS m O M  PATIENTS Aim CORD BLOOD
Normal adults 
(mean + s.d.)
CV-H
patient;
X-H
patients
Cord
blood
Total mononuclear T-cells B-cells
cells (z") (E"8lg+)
19.9 1 2.9 13-5 2  3.1; 5b.9 + 13.8
E.O. 1.8 2.1 -
B.H. 2.3 3.1 -
A.¥ • 2.8 1.5 23.1;
D.B. 3.6 1.1 n.d.
S.C. 5.1 5.7 8.9
V.P. 5.6 2.7 n.d.
G.R. 8.5"^ 3.9 78.0**
R.C. 9.2'"" 5.1; 2^.9
S.J, 10.1^^ 7.2** 31;.^^
C.F. 10.9^ 7.9"^ 61;.6**
J.F. 18.1^ 10.5^ —
C.M. 21.6^ "^ 20.8** 17.1;
J.C. 22.3^ 16.8** -
M.R. 2,h 1;.8 —
G.B.(a) 3.8 i;.l —
S.B.(a) h.3 h-3 -
A.W.(b) 7.1; 3.6 -
D.B.(a) 7.5 7.2** —
J.W.(b) 9.2"^ —
C.L. iL.o** 13.6** —
D.C. 16.2** 12.1:** -
1 2.9 1;.5 0.8
2 7.2 5.9 10.1
3 7.6 6.1: 8.6
h 7.7 6.1 9.3
5 7.8 H.2** 15.9
6 8.8** 12.3
7 13.3^ 11.5^ 13.2
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obtained a value of 39 jf'l for 5’~N partially purified from liver, and Fox 
& Marchant (1976) reported a partially purified from placentae to have
a un of 12-18 j.il» In addition, since the completion of this kinetic study, 
Ed'/rards et al (1970) have reported values of 20-29 for the Km of human 
lympnocyte Comparison of Kii values in the literature should, however,
be undertaken with caution, since certain buffers and detergents have been 
shown to affect the Km of (Burger & Lowenstein, 1970; Nakamura, 1976).
The Km appears to be independent of pH over the pH range 7.0 - 9.It in the 
presence of and 7.0 - 8.7 in the absence of Mg** (Levin & Bodansky,, 1966)
In this study, no evidence has been found to suggest that the low 
5’“N activity found in many GV-H and X-H patients was due to altered enzyme 
kinetics or to the production of a regu3.atory factor. This has since been 
confirmed on a limited scale by Edwards eu al (1978) who found two patients 
with X-H to have a similar Kia to two normals. Although one of the eight 
cord blood samples investigated here had a higher Km than the normal adult 
value, this obviously cannot be regarded as the general reason for cord 
blood mononuclear cells having less ^^-N activity than healthy adults.
Disruption of mononuclear cells discounted the possibility that the 
cells from patients have some of their masked owing to an altered
location within the cells. Since the cells from both patients and normals 
were observed to increase their activity to the same extent on sol­
ubilization with detergent, the cause of the increased activity was not con­
sidered a major issue. However, in view of a recent report by Stanley,
Edwards & Luzio (1979) this point warrants farther discussion. The increase 
in 5)'-N activity in the presence of detergent may occur for two reasons :
(a) The detergent may release latent enzyme activity from intra­
cellular organelles such as vesicles.
.(b) The detergent may stimulate the enzyme itself.
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It has been suggested that appro:d.mately 20^ 2 of the 5‘ -N activity of 
rat liver cells is located in the meiribrane of vesicles within the cells, 
and that solubilization with detergent releases this activity (Stanley,
Edwards & Luzio, 1979). However, this does not appear to be the case with 
human lymphocytes since the particulate fraction of freeze-thawed cells 
did not show an increase in activity over the intact cells. This
particulate fraction had been washed in hypotonic buffer to ensure that any 
vesicles present were permeable to AMP substrate. Nakamura (1976) showed 
that purified from rat liver plasma membranes was stimulated by up to
S0% by the detergent sodium deo:<ycholate, and that the Km was reduced three­
fold, It therefore seems probable that the detergent was directly stimulating 
the enzyme of human mononuclear cells rather than exposing latent activity 
within the cell.
In common with the results of other workers (Quagliata et al, 197^1 
Kramers et al, 1976; Edwards et al, 1978), depletion of T-lymphocytes from 
blood mononuclear cells did not have a significant effect on the 
activity. This has led to the belief that B- and T- cells have a similar 
activity. However, similar depletion experiments with tonsil lym­
phocytes suggested that B-cells have a higher activity than T-cells.
These apparently contradictory results appear to stem from the differences 
in the constituent cell populations of the *non-T^ cell preparations.
Typical figures for the composition of peripheral blood mononuclear cell 
are : T-cells 70,'^; B-cells 13^; and monocytes 16^ (Gmelig-Meyling &
Ballieux, 1977), although some authors believe the percentage of monocytes 
to be even higher (Zucker-Franklin, 197U; Rothbarth,Hendriks-Sturkenboom,
& Ploem, 1976). However, single-cell suspensions of tonsil'cells are nearly 
pure lymphocytes, of which about Ij0-60^ are B-celI.s (Johnson, unpublished 
data; Janossy, de la Concha, Waxdal, & Platts-41111.5, 1976). Thus, while
101
tonsil ’non-T’ cells represent a relatively pure B-cell preparation, 
blood h'lon-T* cells constitute at least ^0% monocytes.
The positive selection of sig* cells from peripheral blood ’non-T* 
cells showed that circulating B-cells have about four times more 
activity per cell than circulating T-cells, and that the E sig cells 
have a very low activity. The low activity on the monocytes was therefore 
•diluting’ the B-cell enzyme activity in the *non-T’ cell preparations. The 
increase in the ^’ -N activity of E sIg cells during culture was consistent 
with the results obtained by Benn.an & Johnson (1978). These authors reported 
an 11-fold increase in the -N activity of monocytes during four days of 
cultivation; vrith a peak activity on day 2, These observations may offer 
an explanation for the higher values of mononuclear cell 5*“N activity ob­
tained for the normal donors in this chapter than the values given in 
chapter 2 (cf. fig 9, 2,Iu2.1. and fig 13, 3.3.1*). The differences were 
not due to the method of cell collection (i.e. defibrinated or heparinized 
blood) since parallel samples collected by each method had the same 
activity. The overnight culture of the cells studied in this chapter 
appeared to cause an increase in activity of unseparated mononuclear cells 
although the activity of E* and sig* cells remained unchanged.
The data presented in table 10 show that normal circulating mono­
nuclear B-cells from adults have more p’-N activi.ty than T-cells. This 
observation is further supported by experiments conducted in co-operation 
with Dr.A.B.B. Webster at the Clinical Research Centre. Cytocentrifuge 
slide preparations of E* and sig cells were stained for using the
histochemical procedure described by Silber et al (1975) • Three to 18 
times more cells were found to stain positively for 5*-N in the B-cell 
preparations than in the T-cell preparations (table 12). Muller-Hermelink
TABLE 12.
HISTOCHB-IICAL DETERMIÎÎATIOH 0? g'-ITTJCLEOTIBASE ON T- AND B-
LYMPHOCYTES EROM NORMAL BUÎtAN BLOOD
Percenbags of positive cells 
Experiment T cells B cells
1(a) 3 22
2(a) 3 #
3(b) 22 53
h(h) 2 2h
5(b) 8 21
•f .
(a) slgx^  lymphocytes were isolated
(b) slg*" lymphocytes were isolated
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(197)') showed that the B-cell regions of human peripheral tissues sections 
could be distinguished from the T-cell regions by the histochsnical demon­
stration of 5'“N activity. It therefore appears that the failure of 
previous workers to observe a difference between the 5*“N activity of B- 
and T” cells from human peripheral blood reflected the heterogeneity of the 
cell-composition of their B- and T- cell * enriched’preparations. This is 
perhaps best illustrated by the work of Uusitalo & Karnovsky (1977b) on mouse 
spleen cells. These authors did not observe a significant difference between
the 5’“M activity of B- and T- cell ’enriched’ populations. However, when
125the spleen cells were labelled with I-anti- Ig prior to staining for 5*~N 
iiistochemically, about 50,5 of the B-cells stained positively for 5 ’“N com­
pared to on].y 10/j of the T-cells. Barton & Goldschneider (1978) have 
recently reported that T-ljanphocj’tes from the lymph nodes and spleen of 
rats have more 5*~N activity than the B-lymphocytes of these tissues. Although 
these experiments are open to criticism on the grounds that the ijurity of 
the 'enriched’ populations was suspect, the histochemical staining of tissue 
sections showed the S’-'N activity to be associated with the T-cell dependent 
regions (c.f. Muller-Hermelink, 197)4, for staining of human tissue sections).
Assuming mean B- and T- cell percentages of 13 and 70^ respectively 
for normal human peripheral blood, B-lymphocytes account for about hO^ of 
the total circulating mononuclear cell activity, and the remaining 60^
is due mainly to the T-lymphocytes. It is therefore apparent that the 
absence of circulating B-cells in. patients with X-H and in some patients 
with CV-H has a significant effect on the mononuclear cell activity.
Similarly, the larger proportion of monocytes found in cord blood (Berman 
& Johnson, 1978) also results in a lower activity of the mononuclear
cells. In addition to the effects of cell-composition, reduced activi­
ties on T- and B-lymphocytes were frequently observed. Patients with CV-H
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were foimd to have a low 5*-N activity as a result of one or more of 
three mechanisms : low T-cell 5' -N activity, reduced numbers of B-cells, 
and low B-cell 5^-N activity. Patients with X-H often had a low T-cell 
activity in addition to their lack of circulating B-cells.
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CHAPTER k
THE SIGNIFICANCE OF ECTO-5^ -NUCLEOTIDASE ACTIVITY ON
FUNCTIONAL LBIKIOCYTES
106
4.1. INTRODUCTION
The experiments in this chapter were designed to investigate 
the consequences of low 5*-N activity in human lyiaphocyfces. It is 
possible that the underlying cause of the immunodeficiency in some 
patients with hypogammaglobulinaemia is due to the failure of lympho­
cytes to migrate to lymphoid tissues such as the lymph nodes or spleen. 
Preliminary results using the ’capillary tube migration’ technique to 
investigate the migration of cells in vitro (George & Vaughan, 1962) 
suggested that the circulating mononuclear cells from some CV-H patients 
showed poor migration (A.D.B. Webster, unpublished results). A more 
extensive Investigation was carried out here, using the same technique, 
to study the migration of circulating mononuclear cells from both CV-H 
and CLL patients. The effect of inhibition of 5*~N activity on the 
migration of normal circulating mononuclear cells was also studied.
The phosphonate analogue of AD.P, AOPCP, wae used as an inhibitor 
of ecto-5’-N activity (Burger & Lowenstein, 1970, 1975). The stability 
of this analogue was investigated, since many of the experiments in this 
chapter involved adding AOPCP to cell cifLtures in order to inhibit the 
5*-N for up to seven days. The effect of AOPCP on the in vitro trans­
formation and imiîiunoglobulin production in response to mitogens was 
investigated. In addition, changes In. the ecto-^’ -N activity of lympho- • 
cytes during transformation were studied in the absence of AOPCP. In 
this manner it was hoped to elucidate any possible involvement of the 
membrane enzyme in lymphocyte activation. Four different mitogens were 
employed in these transformation experiments; concanavalin A (Con A), 
phytohaemagglutinin (PHA),. pokeweed mitigen (Ffl) and protein A. K'JH 
and protein A are known to stimulate populations of both B- and T~ lympho­
cytes (Janossy et al, 1976; Ring den & Rynnel-Dagoo, 1978). By analogy
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with murine systems and from studies with T-cell deficient patients.
Con A and PHA were originally considered to be specific activators of 
T-cells; but it is now clear that these mitogens also stimulate UTA 
synthesis in some B-cells (Phillips Sc. Roitt, 1972 ; Chess, MacDermott,
& Schlossman, 1971;) •
Ü.2. MATERIALS & METHODS
As in chapter 3, only the materials and methods not previously 
described are given here. Sterile precautions were taken where appro­
priate .
h.2.1. Materials
AOPCP ( -methylene adenosine diphosphate)
Boric Acid
Bovine serum albumin
Mitogens: Con A (source; Jackbesn)
PHA
Protein A
Mitomycin C
Th^ rmidine
6-methyl( H) tbjunidine
(sourcerPhaseolus spp.) 
(source:Staph, aureus)
(source :Streptomyces
Caspitesus)
SIGMA
BDH
SIŒ'iA
CALBIOCHEM
CALIFORNIA
l'ÎELLCGl-iE
PHARMACIA
GIBCO
SIffiiA
BDH
RADIOCHEMICAL
CaTRZ,AHERS3m
Cristaseal
Culture flasks; Nunclon Delta Tissue Culture Flasks,
Microculture plates; Cooke Microtitre Flat-Bottom
Tissue Culture plates).
Microcapillary tubes; 10 jH Microcaps
Migration plates
Ultrafilter; Bi 10, 10000 M.W, cut-off
HAWKSLSÏ & SON 
LTD., SUSSEX
GIBCO
STERILBI
DRUMMOND 
SCIS-ITIFIG CO. 
USA.
STERILIN
A^IICON
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L.2.2. Assay for the concentration of AOPCP In cell cultures
The ability of AOPCP to inhibit acti\rity was used to
determine the concentration of the phosphonate in ultrafiltrates of 
spent culture medium. Five ml cultures containing 10^ tonsil lympho­
cytes/ml in R.P.M.I. (bicarbonate)-FCS medium were set up in 10 ml 
culture flasks. These cultures, with or without 200 AOPCP added, 
were incubated in an upright position at 37°C in humidified air with 
S% COg. After four or seven days, the cells were removed by centri­
fugation at 200g for 10 min. The supernatant was diluted with four 
volumes of TBS and ultrafiltrated through a 10000 M.W* cut-off membrane 
to remove enzyme molecules (particularly the 5*“N from the FCS and cell 
fragments) • The concentration of AOPCP in the ‘ultrafiltrates was 
determined by adding 0.3 ml aliquots to 0.2 ml of a tonsil lymphocyte 
suspension in TBS, and assaying for 5^-N activity. A standard curve 
for the Inhibition of by AOPCP was constructed for a range of con­
centrations up to 20 pM AOPCP. Control ultrafiltrates from cell cultures 
to which no AOPCP had been added were also tested for 5*-N inhibition.
Jb .2.3. The capillary migration technique
The method used to investigate the in vitro migration of cir­
culating mononuclear cells was based on the procedure developed by 
George & Vaughan (1962) for guinea pig peritoneal exudate cells. Briefly, 
the cells were packed into a capillary tube and cultured for 18 hr, by ■ 
which time the cells had migrated out of the tube and formed a fan-like 
monolayer on the culture plate (fig 16). The area of this monolayer was 
taken as an index of the cell migration.
Figure 16
mi gr ati on of ce ll s out of capillary tube cu lt ure s
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1 mm
Silicone grease Ca ) was used to fix the capillary tube (B) in 
position in the culture plate. Cells migrated out of the tube 
and formed a fan-like pattern (C),
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Mononuclear cells were obtained by Ficoll-Triosil separation of 
15 ml of fresh defibrinated blood. These cells were washed in R.P.M.I. 
(bicarbonate) culture nedium with 10^ human AB senun, and resuspended 
to a volume of 0,1 - 0.2 ml. This cell suspension was used to fill 
10 jxl ’microcap’ capillary tubes which were then sealed at one end with 
’Cristaseal’ . The tubes were placed in a test-tube padded with cotton 
wool, and centrifuged at 200g for 7 min in order to pellet the cells in 
the capillary tubes. A diamond pencil was used to cut the tubes at the 
cell Interface. The cut tubes were immediately placed in the individual 
wells of a migration plate, and fixed in position with silicone grease. 
The wells were filled with R.P.M.I. (bicarbonate) - AB serum medium, and 
sealed with silicone grease and microscope slide coverslips. After 
incubation of the migration plates for 18 hr at 37^C, they were placed 
in a Durst photographic enlarger and the image of the migration patterns 
projected onto paper for tracing. The traced areas were measured by 
planimetry, and the migration inde:: (M.I.) detenriined as :
M.I. = The mean area of migration of the test cells
The mean area of migration of the control cells
1;.2,.li. Transformation of tonsil lymphocytes by mitogens t the effect 
on the lymphocyte 5^-nucleotidase activity
Tonsil lymphocytes in RR4I (bicarbonate)- AB serum medium were
cultured at 37°C in Nunclon culture flasks at an initial cell density of 10^ 
2cells/cm . Ten or 50 ml capacity flasks were used in an upright position 
so that a cell concentration of about lO^/ml was used. Individual 5*-N 
determinations were performed on separate cell cultures for each day; and 
not by withdrawing aliquots from the same cultures.
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In the Initial experiments involving dose-response curves and 
time-course observations for the four mitogens under investigation, 5ml 
cultures were set up and maintained at 37°C in humidified air with S%
COg. At the appropriate time, 0.2 ml aliquots were removed for the 
determination of the cell concentration using the Coulter Counter, and 
the remainder was washed 3 times in TBS before assaying for activity.
Cell aggregates were frequently found for the first three days in the 
cultures stimulated with either PHA or Con A. This problem was overcome 
by passaging the cell suspensions repeatedly through a syringe needle 
before washing in TBS, and filtering the final suspensions through nylon 
gauze. VPnenever this treatment was necessary, the control cells were 
treated in the same manner.
B- and T- cells were isolated from 25ml cultures of tonsil lympho­
cytes after two or four days culture by a single resetting step with 
neuraminidase-treated sheep eiythi'ocytes. The cultured cells were spun 
on a Ficoll-Triosil gradi.ent to remove any cells that may pass through 
the gradient (eg. dead cells). The interface cells were collected and 
washed once before adding to the En.-rosetting mixture (see 3*2.U.2.).
An aliquot of this cell suspension was removed, subjected to ammonium 
chloride lysis, and washed tîiree times in TBS. This was the ’unseparated 
control*. The rest of the resetting mixture was separated on a Ficoll- 
Hetrizoate gradient to yield En* (T-cells) and En (B-cells). The cells 
were washed three times in TBS and assayed immediately for 5*-N.
Ij..2«5. Lynphocyxe microcultures.
Micro culture 3 of tonsil lymphocytes or peripheral blood mono­
nuclear cells were set up for the studies on ti^ymidine uptake (trans-
I
formation) and immunoglobulin production. Cultures of 0.25 ml of cells
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in R.P.M.I. (bicarbonate)-FCS medium (10^ cells/ml), with or without mito­
gens, were set up in flat-bottomed microplates. The peripheral wells 
were not used for cultures; these were filled with water to prevent the 
evaporation that tends to occur in the outermost wells even in humidi­
fied incubators. The cultures were maintained at 37°C in humidified 
air with COg.
1|.2.5.1 . Thymidine uptake
A stock solution containing one part (^H)-thymidine (l.O mCi/ml;
5 Ci/mmol) and one part *cold* thymidine (5-0 mg/ml) was prepared and 
stored at -20°C. Eighteen hours before harvesting, 2.0 ^1 of the stock 
thymidine solution was added to the microcultures. The cells were 
harvested automatically using a Skatron (Norway) cell harvester. After 
two washes each with PBS, trichloroacetic acid, and methanol, the filters 
containing the acid-insoluble residues were thoroughly dried and placed 
in 5*0 ml of scintillation fluid (12.5 g PPO, 0.25 g POPOP, dissolved 
in 2,5 1 toluene). The samples were left to dissolve for 2 days before 
counting for tritium.
1;.2.5*2. Measurement of IgK in microculture supemates
The IgM present in the supemates of 7-day cultures stimulated 
with 10 jil/ml HvT'l was measured by the double antibody inhibition radio- 
immune assay (Platts-Mills & Ishizaka, 1975). The anti-sera and immuno­
globulins were kindly provided by Dr.T.A.E. Platts-Mills (Dept. Immuno­
logical Medicine, C.R.C.) Rabbit antiserum against purified human IgM 
was made specific for ji-chains by repeated passages through human IgG
113
ininxinoabsorbent columns. Goat anti-rabbit IgG was passed over a human
IgG imriunoabsorbent column to remove cross-reacting antibodies. Human
125IgrI was radiolabelled with I according to the method of Klinman &
Taylor (1969). A stock solution of borate-buffered saline (BBS) was 
prepared by making 360 g NaCl, 12.2 g Boric acid, and 19*5 ml of 1.0 K 
HaOH to 2 litres with distilled water. This stock solution wag diluted 
1:20 and adjusted to pH 8.0 with KaOH or HCl before use. A 3% solution 
(wt/vol) of bovine seiuia albumin in 100 ml of BBS was prepared (BBA), and 
used in the assay to reduce non-specific retention of immunoglobulins on 
the plastic walls of the assay tubes.
Appropriate dilutions (usually 1:6 and 1:66) of the culture super-
nates, and two-fold dilutions of standard IgM solutions (0.002 to 2*0jig/ml)
were made in BBA, and 0.1ml aliquots used for assay. To these samples,
0.1ml of an optimum dilution of rabbit anti-human IgM and normal rabbit
seium in BEA was added with shaking. With the reagents provided, a
1:1500 dilution of anti-Ig and a 1:60 dilution of normal rabbit serum was
used. After leaving the mixtures for two hr at room temperature, 0.1ml 
125
of I-labelled human IgH (2 ng IgM | about 20,000 count s/min/ng) was 
added with shaking. After a further two hr at room temperat'ore, 0.1 ml 
of a 1:1; dilution of absorbed goat anti-rabbit Ig antiserum was added.
The samples were left overnight at then washed three times with BBS
at and the radioactivity in the precipitate counted.
b.2.6. Inhibition of transformation by mitomycin C.
In some experiments, lymphocyte subpopulations were treated with 
mitomycin G in order to inhibit transformation (Bach & Voynow, 1966).
The cells were incubated at 37°C for 30 min with 50 jig/ml mitomycin C in
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in R.P.M.I, (hepes)-FCS medium, then washed three times in medium to 
remove the inhibitor before culturing.
lj.2.7* Patients studied
The CV-H and CLL patients investigated here were described in 
chapter 2,
U*3» RESULTS
I4.3.I. The inhibition of 5*-N activity by AOPCP ; the stability of 
the inhibitor during cell culture
The presence of 50 JîM AOPCP typically resulted in 80-90^ inhibi­
tion of human lymphocit-e ecto-5*-H activity (fig 17). This inhibition 
was reversible; full actiid.ty being restored by washing the cells in 
TBS, The inhibition of was used to estimate the concentration of
AOPCP remaining in the ultrafiltrates of spent cell cultures after 7 
days incubation at 37°C. AOPCP was found to be stable under these con­
ditions for at least 7 days (table 13).
TABLE 13
THE STABILITY OF AOPCP DURBIG CELL CULTURE
Days in culture Concentration (pM) of AOPCP
(mean ? s.d, for 5 determinations)
0 198 + 13
1 188 + 16
7 212 + 23
Fiç-jre 17
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U.3-2. The in vitro migration of circulating mononuclear cells■ " T. > m --- - - ■    --- —^ - - -   ■- ■ ■ — - - -- -- - -  ------- - --
The migration of circulating mononuclear cells from patients and 
healthy individuals was investigated using the capillary tube culture 
technique. Because of the day to day variability of the results ob­
tained with this procedure, the migration of cells from patients was 
always expressed as a fraction of the migration observed with control 
cells in the same experiment (ratio = M.I.). Two patients investigated 
on different days with the same control gave reproducible results when 
the migration was expressed as the M.I. When plotted on an appropriate 
logarithmic scale, the mean M.I. of 12 CV-H patients was not significantly 
different from unity, but the mean M.I, for nine CLL patients was signi­
ficantly less than unity (fig 18). The CLL patient T.R., who had a 
supranormal level of activity, had a typical M.I. of 0.^8 for a
CLL patient.
The presence of 250 jiM AOPCP in the cell cultures did not affect 
the migration of normal circulating mononuclear cells (table lit). 
Lymphocytes isolated from normal circulating mononuclear cells migrated 
to a similar ext.ent to the total mononuclear cell preparations (table l5).
TABLE IL
THE EFFECT OF AOPCP OH THE IN VITRO MIGRATION OF CIRGUIATE-TG 
MOHONUCLEAR CELLS
Relative area of migration 
(jH S . d .  for n determinations )
Control cells 100 2  5 (n = 7)
Cells + 250 ^  AOPCP 97 1  (n = 7) p 0.05
TABLE 15
THE IN VITRO MIGRATION OF CIRCULATING LYMPHOCYTES ISOLATED BY E-RQSETTIMG
Relative area of migration 
(_+ s.d. for n determinations)
Total mononuclear cell
population 100 10 (n = 6)
E-rosetting cells 93 + 7 (n = 5) p 0.05
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Fi eg: re 13
THE TN VITRO MIGRATION OF CIRCULATING MONONUCLEAR CELLS OBTAINED 
FROM PATIENTS WITH CLL AND FROM PATIENTS WITH CV-H
1.0
0 .5
0
CD
O
-0 .5 '
“1.0—
0
CLL
(p<  0.001)
o
CV-H
The vertical bars represent the mean +_ s.d», and. the p values denote 
the probability that the mean M.I. equals unity.
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Ij.3.3 » The effect of mitogenic transformation on hiuian lymphocyte
5’-nucleotidase activity
Dose-response curves were constructed for the effect of each of
the four mitogens (PWM, protein A, RIA, and Con A) on the 5* -N activity
of tonsil lymphocytes by day I; of culture (fig 19). The results were
expressed as the ratio: 5*-N per cell of stimulated cultures in order
5 ’ “N per cell of control cultures
to facilitate the comparison of results obtained from different tonsil 
cultures. This was necessary because unstimulated tonsil cultures 
frequently, but inconsistently, showed a loss of 5*-N activity per cell 
during the first day of culture (table 16). The doses of RJM are given 
as a function of the volume of the dilution reconmended by the suppliers. 
A suitable dose of each mitogen was used to construct time-course plots 
(fig 20). A decrease in activity per cell was generally observed
by the second or thi.rd day of culture in the presence of mitogen. This 
decrease in 5*-N activity just proceeded, or coincided with, the increase 
in cell numbers (fig 21). While protein A-, Con Â-, and PHA- stimulated 
cultures continued to show a decrease in activity till uhe fourth 
or fifth day of culture, PVM-stiiriulated cultures did not show any further 
reduction of activity after the third day of culture.
TABLE 16
THE EFFECT OF CULTURE ON mSTBIUR^TED TONSIL LlllPHQCITES
E x p e r i m e n t __________ 5’ -H activity (nniol/hr/lO^cells)
Day 0 Day 1 Day 2 Day 3 Day ij.
1
2
3
hr
5
6
h3 31 33 39 39
3Ù 15 n.d."^ Ih n.d.
26 11 13 12 12
21; 20 18 iL 17
23 . n.d. 27 32 2li
22 12 15 17 15
* , n.d. = not determined
Figu.re 19
DOSE-RESPOMSS PLOTS: THE EFFECT OF MITOGENS ON" T?IS LY?4PH0CYTE 
5 ' ^ MUCLEariDASS AND CELL NUMBERS BY DAY 4 OF CULTURE
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The effect of mitogenic stimulation on the cell concentration (o) and 
the 5'-nucleotidase activity per cell (□) by Day 4 of culture is shovvn. 
The mitogen dose is given as jig/ml for PHA,Protein A, and Con A ; and 
as Lil/ml for PVLI. The vertical bars represent the standard deviation 
of the geometric meah values from at least three experiments. The 
results shovn for Protein A were obtained from a single experiment.
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Figure 20
TIi-15-COURSE OF THE EFFECT OF MITOGEN STIMULATION CM THE 
5'-NUCLE0TIDASE ACTIVITY OF TONSIL LYMPHOCYTES
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The doses of mitogens employed were: PWM, 10 ipl/ml ; PHA, .2,5 jug/ml. 
Protein A, 25 jiq/ral ; Con A, 10 pg/ml. The vertical bars represent 
the standard deviation of the geometric mean values from three or 
more experiments.
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Figure 21
CELL PROLIFERATION IN MITOGEN-STIKULATED LYMPHOCYTE CULTURES
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The geometric mean values of the ratio of cell concentrations 
from at least three experiments are given.
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Both Con A and RIA are known to inhibit human lymphocyte 
activity under certain conditions (Webster et al, 1978)* However, 
the enzyme activity was unaffected, when tonsil lymphocybes were in­
cubated Tvlth these mitogens (at the concentrations shown in fig 20) 
for one hour in R.P.M.I. (bicarbonate)-AB serum, before washing in 
TES and assaying for S*-N* The presence of serum in the incubation 
medium was responsible for relieving the inhibition by the mitogens; 
as shown by the results in table 17*
TABLE 17
THE DÎHIBITION OF LYMPHOCYTE ECTO-5* “'MUCLEOTIDASE BY CON A
Conditions of experiment Percentage inhibition of
activity by Con A
10 pg./ml Con A 100 pg/ifil Con A
Cells incubated 2  mitogen in;
(a,) R.P.M.I. (bicarbobate) 75 85
(b) R.P.M.I. (bicarbonate) + 10)t i
serum
for 1 hr, then washed x 3 in
TBS.
Cells assayed for 5*~N# + mitogen 73 80
in the assay.
Because the four mitogens employed are believed to have different 
specificities, it was decided to investigate the effect of each of these 
mitogens on the B- and T- cell 5’-H activity. Table 13 summarizes the 
results obtained with En"*" and En’*’ populations isolated by a single 
resetting procedure from day h tonsil cultiires. Perhaps sur­
prisingly, Con A - transformed T-cells appeared to be unaffected, while 
the B-cells had considerably less 5*-N activity than B-cells from un­
stimulated cultures. All four mitogens caused a reduction of B-cell 
5^-N activity; this reduction being more marked with the "T-cell mitogens".
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TABLE 18
THE 5'-:mCLE0TICASE ACTIVITY OF TONSIL T- AND B- CELLS ISOLATED FROM 
MIT0GEH-STI2-mLATED CULTURES APIER L DAYS
Mitogen Total lymphocytes T-cells B-cells
PHA 3.9 + 1,0 3,0 ^  0,6 7.U 2 )t-6
2,5 ^ g/ial (13.3 * 6.3) (3.3 2 1.1) (U3.2 212.b)
Con A 6.7 1 3.0 6.1 2 2.8 11.0 2 1.3
10 J2g/ml (lS.3 1 6.3) (6.7 2 0.6) (38.3 222.0)
10.L + 2.6 7.U 2 0.7 17.1 2 3.0
10 jil/r.Ll (13.3 i 6.3) (3.3 21-1) (b3.2 212.b)
Protein A 3.3 _+ 2.3 2.b 2 1-0 18.b 210.2
25 Ng/zal (lb.7 2 U.3) (7.6 2 1.6) (bo.6 216.0)
The values shown are the 5*-“N activities (nmol AM? / hr/ 10 cells) of 
cells recovered from li-day cultures. The figures 1ji parentheses are 
the activities of cells obtained from parallel unstimulated control 
cultures. The mean + s*d. for three experiments is given.
12‘1
PHA and Con A. PHA and Protein A both reduced the T-cell activity,
but RJIi caused a slight increase. Time coarse plots of T- and B- cell 
5’~N activity in cultm’es stimulated with FÆI and Con A are shov«n in 
fig 22. With PVM, both T- and B-cell activities remained unchanged after 
two days of culture. However, Con A - stimulated cultures revealed a 
transient increase in T - cell activity which proceeded cell-prollfora­
tion .
The effect of AOFCP on the -thymidine uptake of mitogen- 
stimulated cells
The uptake of %-thymi.dine by mitogen-stimifLated cells was used 
as a measure of cell trains formation. Tonsil lymphocyte microcultures, 
with and without 200 jili AOPCP present, were fed ^-thymidine after hr 
and harvested iBh'r later* In order to avoid the possibility that the 
^backgrounds transformation of T-cells may mask the effect of AOPCP on 
B-cell transformation in PWH-stimulated cviltxires, T- and B- lymphocytes 
were isolated from tonsils by En-rosetting and unwanted transformation 
was inhibited by treatment with mitomycin C. Mitomycin-treated cells 
(i.e. Tm and Bm) were mixed with equal numbers of untreated cells, and 
stimulated with either 2.p pg/ml PHA or 10 jil/ml B'IM. The results in 
table 19 show that the transformation of both B- and T-cells was unaffected 
by the presence of AOPCP. The ^H-uptake by BiM stiir.ulated cultures was 
also investigated between 78-96 Irrrs, and the same results were obtained.
I|.3e9* The effect of AOPCP on the immunoglobulin synthesis by B#I- 
stimilated l^ rniphocytes
The effect of 2pO jîM AOPCP on the amount of IgH secreted by normal 
circulating lymphocytes was investigated. Since cell transformation is
125
Fleure 22
EFFECT OF CON A AND PWM ON THE 5 ’-NUCLEOTIDASE OF TONSIL
E- AND T- CELLS
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a necessary prerequisite for in vitro iiriniunogj-obulin synthesis, the 
AOPCP was added to R'M-stiniiilated rfiicrocultnres at day 0, 1, 2, or I|. 
in case transformation was affected in a manner that went undetected 
in the previous experiments (^ ^3»^. ). The amount of Igîi secreted into 
the triplicate supemates by day 7 was measui’ed using the double anti­
body inhibition radiolmrrune assay. The results obtained f/rith circula­
ting mononuclear cells from three normal donors are summarized in table 
20. The presence of 2^0 jM AOPCP, whether added on day 0, 1, 2 or day I;, 
did not affect the production of IgM in the micro cultures.
TABLE 20
TEE EFFECT OF AOPCP ON THE IgM PRODUCTION BY PERIPHERAL BLOOD 
LYMPHOCYTES STDiULATED WITH
DonCi F M AOPCP
IgH secreted (pg/ml)
AOPCP added to cultures at ;
Day 0 Day 1 Day 2 ' Day 1;
B.P.
0.18
0.7
o.L 0.7 0.8 0.7
M.C.
0.06
0.9
1.2 0.9 1.1 1.1
M-.T
0.16
0.6
o.< 0.Î1 0.1; O.ii
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Ij.U. Discussion
No evidence was found to support the idea that circulating mono­
nuclear cells from CV-H patients migrate less well in vitro than those 
cells from healthy individuals. In addition, ecto-5*-"N activity did 
not appear to be necessary for cell migration in this system. The poor 
migration observed with CLL cells may either reflect the composition of 
the mononuclear cell preparation, or a genuine impairment of migration 
that may be relevant in vivo.
Because of the negative result obtained with cells from CV-H 
patients, and because of the apparent non-involvement of ecto-^'-N in the 
migration of these cells in vitro, a thorough investigation of this tech­
nique was not undertaken. However, it should perhaps be mentioned that 
until the last decade, it was generally considered that lymphocytes did 
not migrate to a significant extent compared to macrophages. Thor et al 
(1968) reported that neither human lympli-node cells nor peripheral cells 
migrated freely using the capillary tube culture technique^ although the 
lymph-node cells migrated well after 72 hr in culture. S^rberg & Bendixen 
(1967) had previously been successful in demonstrating the migration of 
human peripheral blood mononuclear cells using this technique. However, 
there still remained the possibility that the migrating ceils were macro­
phage type cells (monocytes) rather than lymphocytes. Freidman et al (1969) 
reported that the cells from a number of murine tissues could be observed 
to migrate out of capillary tube cultures, and that lymphocytes and macro­
phages migrated to the same extent* The results in this chapter also 
show that human circulating lymphocytes (E-rosetting cells) migrate to the 
same extent as the total circulating mononuclear cell nrenarations.
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In conclusion, it is not unreasonable to assume that lymphocyte 
migration was being observed in the experiments described in this chapter. 
However, the reason for the poor migration observed by CLL cells was not 
determined. It remains possible that, in this system, B-cells may not 
migrate to the same extent as T-cells. O^Heill & Parrott (1977) reported 
that human peripheral blood mononuclear cells show better random migration 
through filters in Boyden Chambers than do T-lymphocytes. However, in this 
system ■'d.rtually no migration was observed by T-cells unless they had pre­
viously been cultured for 72 hr or had been activated by mitogens. Thus, 
direct comparison of results obtained with these two techniques cannot be 
made, and the relevance of these in vitro migration results to the situation 
in vivo is questionable.
A decrease in the 5*“11 activity of human circulating mononuclear cells 
stimulated vith PHA has previously been reported (Quagliata et al, 197h) • 
These authors measured the -N activity as a function of the total, cell 
protein, and attributed the moderate decrease (2^-^0^) in the enzyme activity 
on day 9 of culture to the decreased surface membrane area per volume of 
the larger, stimulated, cells, This was shown not to be the case in the 
experiments performed here, since the activity was measured as a
function of the number of cells. The transient increase of T-cell 
activity in Con A- stimulated cultures has an analogy in a murine system. 
Robinson (1978) and Johnson, Edwards & Robinson (1979) showed that Con A- 
stimulated spleen cell cultures had an increased activity per cell on .
day 2, but by day k the activity was dramatically diminished.
EvaJ-uation of the stability of AOPCP in cell cultures was of para­
mount importance since the inhibition of by this compound is reversible 
by simply washing the cells. Its stability allowed its incorporation into
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the cell culture medium in order to investigate the importance of 
activity for transformation and immunoglobulin production by human 
lymphocytes. Selective inhibition of T- or B- cell transformation by 
treatment with Mitomycin C was necessary to determine whether either of 
these populations was selectively affected by AOPCP; especially in view 
of the apparent broad specificity of the mitogens. In conclusion, inhibi­
tion of activity with AOPCP did not affect the transformation of B-
or T- ceils, and neither did it affect the production of immunoglobulin 
in F/vM-stimulated cultui‘es.
131
CHAPTER $
GENERAL DISCUSSION
132
The discovery that ADA- and PNP- deficiency were the cause of the 
iramune-dysfunction in some immunodeficient patients (see 1.6.2.) led to 
the speculation that the low levels of activity may be the biochemical
defect responsible for the immunodeficiency in some patients with hypo- 
gammaglohulinaemia. Normal adult B-lymphocytes have a high specific 
activity of 5'-N (3^3*5.), and since the circulating B-cells are either 
absent or functionally defective in X-H and CV-H patients, it seemed possible 
that the lov; activity could be relevant to the aetiology of the disease.
However, the results presented in section show that the low
activities in these patients were not confined to the B-cell population.
While the absence or reduced percentage of B-cella in X-H and CV-H patients 
contributed significantly to the low $'-N activity of the total mononuclear 
cells, a low T-cell activity was also observed in many patients. The
number of CV-H patients with a low T-cell activity was found to be in
excess of the percentage of patients showing a functional defect of these 
cells (Webster & Asherson, 197^; de Cast et al, 1979) and no correlation 
was observed between the activity and the ability of the patients*
T-cells to provide 'help* for the in vitro production of immunoglobulin by 
normal B-cells (de Gast, Platts-Mills & Rowe, unpublished data). The B-cells 
from some CV-H patients had a normal level of activity despite their
functional defect. With the finding that inhibition of activity did
not affect the in vitro transformation or immunoglobulin synthesis of normal 
lymphocytes (4.3.4. and 4.3» 9. ), it now appears unlikely that the low level 
of activity is directly responsible for the disease in CV-H and X-H.
At this stage it is not possible to rule out indirect effects of 
5*-N activity on immune-function. For example, the recent report of the 
interaction of the enzyme with actin (Hannhers & Rohr, 1978) and the
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presence of actin on the surface of lymphocytes, in particular B-lympho- 
cytes (Owen et al, 1973)i raise the possibility that the enzyme could 
be involved in the migration of lymphocytes in vivo. Although the 
results in this thesis do not provide any evidence for impaired migration 
of lymphocytes from CV-H patients, or any dependence of migration upon 
5’-N activity (4 . ), it should be emphasized again that the resifLts 
obtained with the in vitro technique may not adequately reflect the 
migration of cells in vivo.
Unlike ADA- and PNP- deficiency, in which the respective enzymes ■ 
are completely absent or present in barely detectable quantities, the 
deficiency in hypogamraaglobulinaemic patients is only partial.
With such a partial deficiency one might expect to find altered enzyme 
kinetics through a regulatory factor or a gene defect. However, no 
evidence was found to substantiate this view (3.3.2. and 3.3*3*).
There appears to be fewer enzyme molecules present: as was found to be 
the case with CLL patients by using a fluoiescent antiserum to 
(La Mantia et al, 1977). It is still possible that there is an absence 
of subpopulations of both B~ and T- lymphocytes that are particularly 
rich in 3*-N activity. If this is the case, future investigations with 
an appropriate specific antiserum to may allow the separation of
3’-N-positive cells on the fluorescent activated cell sorter (Loken & 
Herzenberg, 1975) and the consequent characterization of these cells.
The change in 3'-% activity of tonsil lymphocytes during mitogen- 
induced transformation (4.3.5*) suggests that blast cells in vivo may 
have a different 3*-N activity to the circulating non-activated lympho­
cytes, and that the enzyme may be under some regulatory control. Of 
particular interest was the transient increase in the 3'-^ activity of
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Con A-stimulated lymphocytes before the onset of cell proliferation; 
thus possibly implicating the enzyme in the activation process. However, 
the inability of AOPCP to affect the mitogen activation of these cells 
contradicts this view. No explanation can be offered at this stage.
The effect of blast transformation on the level of activity
on tonsil lymphocytes was not unexpected in view of the number of 
reports demonstrating changes in the 3*-N activity during cell 
differentiation and development. Examples include: developing chick 
embryo brain (Manzoli, Ipata & Wegelin, 1971)» developing rat sperm 
(Xuma & Turkington, 1972), regenerating rat liver (Kasuda, Nishimura,
Nojiri & Murano, 1976) and developing chick cartilage (Rodan, Bourret,
& Cutler, 1977)® In addition, the increase in monocyte activity
during in vitro cultivation (3 . : Berman & Johnson, 1978) may reflect 
monocyte-macrophage differentiation. 'Activated* mouse peritoneal macro­
phages have less 3'-N activity than normal resident macrophages, and the 
level of the enzyme is very dependent upon the agent used to induce the 
inflammation (Edelson & Cohn, 1976).
There is circumstantial evidence which suggests that the low 3'-# 
activity found on the lymphocytes of many patients with h^rpogammaglobulinaemia 
may reflect a stage of maturation arrest in these cells. From functional, 
morphological and surface marker studies, the malignant cells of CLL 
patients are believed to be blocked at an early stage of differentiation 
(Salmon & Seligman, 197^; Catovsky et al, 1978). In this respect it 
is interesting that the CLL patient T.R., who had a supranormal level of 
5'-N activity, had leuicemic cells that appeared to be better differentiated 
than was characteristic of most CLL patients (see 2.4.1.4. ). Both T- 
and B- lymphocytes from cord blood, which have less 3*-N activity than the
K13o
corresponding celle from adults (3.3.6.), are also considered to be 
immature (Hayward & Lawton, 1977). Further support for the 'maturation 
arrest’ hypothesis may yet be gained from the isolation and study of 
bone-marrow B-cells which appear to be immature (de Gast & Platts-Mills,
1979).
The heterogeneity of 3*-N activity in CLL patients warrants some 
comment. It has been widely held that the clonal expansion of a 3*-N- 
negative or a 3'-N-positive cell gives rise to leukemic cells with a 
correspondingly low or high 3*-N activity (Silber et al, 1975; 
laMantia et al, 1977). This view arose mainly from histochemical 
studies: the leukemic cells from most CLL patients do not stain for the 
enzyme, while those patients with positively-stained cells have a supra­
normal level of 3'-N activity (Silber et al, 1975). It could be argued 
that those patients with high activity possess cells that are blocked
at a later stage of differentiation than the majority of CLL patients.
This appears to be the case with the one patient studied in this thesis.
This patient, T.R., has a activity that is about 2-5 times the normal
B-cell activity in healthy adults. The leukemic cells of this patient 
could be considered as having a 3*-% activity comparable with some normal 
B-cells since nearly lOCfo of the cells from this patient stained positively 
for 3*-N histochemically (Matamoros, unpublished data) compared with 
22-33^ of the B-cells from normal peripheral blood (table 12, 3.4.).
The high specific activity of 3*“N activity on normal circulating 
B-cells is probably relevant to the large variation of mononuclear cell 
3'-N activity observed among normal individuals. The proportion of B-cells 
in normal circulating mononuclear cell populations has been reported to 
range from 4,3 - 26.2^ in a sample of 23 subjects (Gmelig-Heyling & Ballieux, 
1977)* Using the 3*-N values shown in table 9 (3.3.5.) it can be calculated
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that a mononuclear cell ssimple containing 20^ B-cells will have about 
double the 3'-N activity of a sample containing only 5^ B-cells,
The high 3'-N activity of B-cells has also been suggested to be 
the reason for the selective impairment of T-cell function in PNP- 
deficient patients and in a minority of ADA-deficient patients (Carson 
et al, 1979; V/ortman, Mitchell, Edwards & Fox, 1979). These workers 
have investigated the effect of deoxy-adenosine on human B- and T- 
cell lines, and found the T-cells to be more susceptible to the toxicity 
of this deoxyribonucleoside. Of the cell lines investigated, 
activity was higher in the B-cell lines than in the T-cell lines; other 
enzymes relevant to deoxy-adenosine metabolism were present in similar 
quantities in all cell lines. Although Webster et al (Manuscript in 
preparation, 1979) have since shown that this pattern of 3*-^ activity 
is not true of all B- and T- cell lines, this does not affect the 
reasoning of these authors since the cell lines were merely being employed 
as models of high and low activity in lymphocytes, 3’~N activity
was suggested to be important in dephosphorylating the deoxy-AMP formed 
from added adenosine; thus preventing the accumulation of the toxic 
metabolite, deoxy-ATP, However, this proposed role for depends on
the enzyme being located within the cell, Carson et al (1979). showed 
that the enzyme of the cell lines studied was an ecto-enzyme, and the same 
is true of normal circulating lymphocytes. This appears to be a major 
drawback to this hypothesis. It is possible that a small percentage of the 
5*-N activity is located within the cell and that this is functionally 
important. Alternatively, the active site of the enzyme may be accessible 
to both intracellular and extracellular substrate (Arch & Newsholme, 19?8)
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although there appears to be no evidence to support or contradict this 
view. Further investigations on the possible sites of action of the 
membrane-bound 3*-N will be necessary to elucidate this problem.
Arch and Newsholme (1978) have reviewed the evidence for a hormonal 
role of adenosine. These authors proposed that ADA and adenosine
kinase were important in regulating the concentration of adenosine.
Because this hypothesis necessitated an intracellular site of action of 
5’“N activity, Arch & Newsholme raised the novel possibility that the 
membrane-bound enzyme may be capable of hydrolysing both intracellular and 
extracellular substrate, Drury (1936) suggested that adenosine may be 
involved in the control of blood flow, and it has since been shown that 
physiological concentrations of adenosine cause vasodilation or 
vasoconstriction in a number of mammalian organs (Berne, 1963; Scott, 
Daugherty, Dabney & Kaddy, 1965; Haddy & Scott, 1968; Berne, Rubio &
Curnish, 197'+)* Seegmiller, V/atanabe & Schreier (1977) have reviewed 
the effect of adenosine on in vitro lymphocyte function. Exogenous 
adenosine enhances cell proliferation and antibody production at low 
concentrations, but inhibits at concentrations of around 1 mM or more.
The presence of an inhibitor of ADA lowers the concentration at which 
adenosine becomes inhibitory. Of particular interest here is the observation 
that PHA-stimulation of human lymphocytes resulted in an increase in the 
rates of phosphorylation and deamination of adenosine, together with an 
increase in the amount of ADA secreted into the extracellular medium.
This, together with the reduction of p'-N activity of PHA-stimulated 
lymphocytes observed in this thesis (4.3.3,) suggests a concerted mechanism 
to reduce the concentration of adenosine during transformation.
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At high concentrations of adenosine, the relative rates of phosphorylation 
and dephosphorylation suggest that the ADA is acting as à spillway for 
removing inordinately high concentrations of adenosine.
Burnstock (19?2, 1977) has postulated the presence of ’pui'inergic 
nerves' supplying a number of organs, including the gastrointestinal 
tract, lung, trachea, seminal vesicles, bladder, oesophagus, eye, and ' 
probably parts of the cardiovascular and central nervous systems. ATP 
was shov/n to be the most likely neurotransmitter, and a role for 
was proposed in the inactivation process. The enzymes, ATP-ase, 
and ADA are together capable of rapidly breaking down ATP to pharma­
cologically inactive compounds. In this case, the proposed role for is
consistent with the extracellular site of enzyme action. However, it 
remains to be seen whether a similar role exists for the lymphocyte enzyme 
in, for example, intracellular communication.
In conclusion, no evidence was found to implicate the low levels 
of activity as the cause of the immune-dysfunction in CV-H and X-H
patients. Rather, the activity appears to reflect the absence of
certain cells and the 'immaturity’ of some of those cells present. The 
significance of these results as regards the function of the enzyme is 
not immediately apparent.
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